RxNorm Semantic Concepts Index - 259
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "259".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2590 | Clobetasol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2590 | Clobetasol | Designated preferred name (PT) | YES | |
| RxCUI: 2590 | Clobetasol | Full form of descriptor (FN) | YES | |
| RxCUI: 2590 | Clobetasol | Designated preferred name (PT) | YES | |
| RxCUI: 2590 | Clobetasol | Full form of descriptor (FN) | YES | |
| RxCUI: 259004 | nonoxynol-9 3.5 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259004 | nonoxynol-9 3.5 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259004 | nonoxynol-9 3.5 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590049 | Perilla frutescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590050 | upadacitinib 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590051 | upadacitinib 30 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2590052 | upadacitinib 30 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590053 | upadacitinib 30 MG [Rinvoq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590054 | RINVOQ 30 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590054 | RINVOQ 30 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590054 | RINVOQ 30 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590055 | upadacitinib 30 MG Extended Release Oral Tablet [Rinvoq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590055 | upadacitinib 30 MG Extended Release Oral Tablet [Rinvoq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2590060 | fructooligosaccharide / Saccharomyces boulardii | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2590061 | fructooligosaccharide / Saccharomyces boulardii Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2590062 | fructooligosaccharide / Saccharomyces boulardii Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2590063 | fructooligosaccharide / Saccharomyces boulardii Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2590064 | fructooligosaccharide 200 MG / Saccharomyces boulardii 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590064 | fructooligosaccharide 200 MG / Saccharomyces boulardii 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590174 | treprostinil 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590175 | treprostinil 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590175 | treprostinil 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590176 | treprostinil 20 MG/ML [Remodulin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590177 | Remodulin 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590177 | Remodulin 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590177 | Remodulin 20 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590178 | menthol 2.1 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590178 | menthol 2.1 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590180 | Apis cerana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590181 | California blackberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590182 | Nerium oleander whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590183 | Periplaneta australasiae extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590184 | Polistes fuscatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590185 | Tabanus nigrovittatus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25902 | Glutaconyl-coenzyme A decarboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 25902 | Glutaconyl-coenzyme A decarboxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25902 | Glutaconyl-coenzyme A decarboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 259021 | glycolic acid 12 % / lactic acid 6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259021 | glycolic acid 12 % / lactic acid 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259021 | glycolic acid 12 % / lactic acid 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259022 | silymarin 100 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590266 | cypermethrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259029 | glucosamine HCl 200 MG / glucosamine sulfate 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259029 | glucosamine HCl 200 MG / glucosamine sulfate 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259033 | rapacuronium 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259034 | beractant 25 MG/ML Intratracheal Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259034 | beractant 25 MG/ML Intratracheal Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259034 | beractant 25 MG/ML Intratracheal Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 259034 | beractant 25 MG/ML Intratracheal Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2590341 | astaxanthin 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2590342 | astaxanthin 12 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590342 | astaxanthin 12 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25904 | Ornithine acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 25904 | Ornithine acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 25904 | Ornithine acetyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259041 | charcoal 250 MG / simethicone 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259046 | estrogenic substances 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259047 | gentamicin 0.4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259048 | phenylpropanolamine HCl 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259048 | phenylpropanolamine HCl 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259049 | niacin 150 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259049 | niacin 150 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259049 | niacin 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259049 | niacin 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259049 | niacin 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259052 | prednisolone 0.2 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259052 | prednisolone 0.2 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259052 | prednisolone 0.2 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259052 | prednisolone 0.2 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259053 | quiNIDine gluconate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259053 | quiNIDine gluconate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259053 | quiNIDine gluconate 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259054 | triamcinolone 4 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590592 | 1-kestose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590593 | Acer pensylvanicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590594 | Ailanthus altissima fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590595 | Alnus rhombifolia bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590596 | Aloe spicata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590597 | Amaranthus hybridus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590598 | Antirrhinum majus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590599 | Atriplex polycarpa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25906 | Glutamate dehydrogenase (NAD(P)^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25906 | Glutamate dehydrogenase (NAD(P)^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 25906 | Glutamate dehydrogenase (NAD(P)^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 259060 | theophylline 100 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259060 | theophylline 100 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590600 | Baccharis pilularis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590601 | blue tilapia whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590601 | blue tilapia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590602 | Breea segeta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590603 | Camellia chekiangoleosa seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590604 | Camelus bactrianus hair extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590605 | Carya laciniosa bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590606 | Cavia porcellus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590607 | cyclosporine 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590607 | cyclosporine 1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590608 | cycloSPORINE 0.1 % Ophthalmic Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2590609 | Verkazia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2590610 | cyclosporine 1 MG/ML [Verkazia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590610 | cyclosporine 1 MG/ML [Verkazia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590611 | Verkazia Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2590612 | cyclosporine Ophthalmic Suspension [Verkazia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2590612 | cyclosporine Ophthalmic Suspension [Verkazia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590613 | Verkazia 0.1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590613 | Verkazia 0.1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590613 | Verkazia 0.1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590613 | Verkazia 0.1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590614 | dabigatran etexilate Pellet Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2590615 | dabigatran etexilate Oral Pellet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2590616 | dabigatran etexilate 110 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590616 | dabigatran etexilate 110 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590616 | dabigatran etexilate 110 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590617 | Pradaxa Pellet Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2590618 | dabigatran etexilate Oral Pellet [Pradaxa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2590619 | Pradaxa 110 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590619 | Pradaxa 110 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590619 | Pradaxa 110 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590620 | dabigatran etexilate 150 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590620 | dabigatran etexilate 150 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590620 | dabigatran etexilate 150 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590621 | Pradaxa 150 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590621 | Pradaxa 150 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590621 | Pradaxa 150 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590622 | dabigatran etexilate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590623 | dabigatran etexilate 20 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590623 | dabigatran etexilate 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590623 | dabigatran etexilate 20 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590624 | dabigatran etexilate 20 MG [Pradaxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590625 | Pradaxa 20 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590625 | Pradaxa 20 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590625 | Pradaxa 20 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590626 | dabigatran etexilate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590627 | dabigatran etexilate 30 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590627 | dabigatran etexilate 30 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590627 | dabigatran etexilate 30 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590628 | dabigatran etexilate 30 MG [Pradaxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590629 | Pradaxa 30 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590629 | Pradaxa 30 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590629 | Pradaxa 30 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590630 | dabigatran etexilate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590631 | dabigatran etexilate 40 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590631 | dabigatran etexilate 40 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590631 | dabigatran etexilate 40 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590632 | dabigatran etexilate 40 MG [Pradaxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590633 | Pradaxa 40 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590633 | Pradaxa 40 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590633 | Pradaxa 40 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590634 | dabigatran etexilate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590635 | dabigatran etexilate 50 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590635 | dabigatran etexilate 50 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590635 | dabigatran etexilate 50 MG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590636 | dabigatran etexilate 50 MG [Pradaxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590637 | Pradaxa 50 MG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590637 | Pradaxa 50 MG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590637 | Pradaxa 50 MG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590638 | Delphinium ajacis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590639 | Dianthus caryophyllus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590640 | Dianthus superbus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590641 | emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590641 | emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590641 | emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590642 | emtricitabine 120 MG / tenofovir alafenamide 15 MG [Descovy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590643 | Descovy 120 MG / 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590643 | Descovy 120 MG / 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590643 | Descovy 120 MG / 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590644 | Ephedra nevadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590645 | fructosylnystose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590646 | Gladiolus communis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590647 | Hedychium flavescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590649 | Ipomoea digitata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590650 | Iva angustifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590651 | nystose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590652 | Neurotensin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590652 | Neurotensin | Designated preferred name (PT) | NO | |
| RxCUI: 2590652 | Neurotensin | Full form of descriptor (FN) | NO | |
| RxCUI: 2590653 | Kalimeris indica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590655 | lidocaine / phenylephrine Rectal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2590656 | lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590656 | lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590656 | lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590657 | Ligustrum lucidum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590658 | Lonicera canadensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590659 | Lupinus elegans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590660 | Magnolia x alba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590661 | maltose anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2590662 | Melaleuca viridiflora whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590663 | Pongamia pinnata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590663 | Pongamia pinnata whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590664 | Narcissus poeticus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590665 | colloidal oatmeal 0.013 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2590666 | colloidal oatmeal 1.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590666 | colloidal oatmeal 1.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590666 | colloidal oatmeal 1.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590667 | Paeonia x suffruticosa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590668 | PEG-150 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590669 | pemetrexed monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2590669 | pemetrexed monohydrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590670 | pemetrexed 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590670 | pemetrexed 25 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590671 | pemetrexed Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2590671 | pemetrexed Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590672 | PEMEtrexed 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590672 | PEMEtrexed 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590672 | PEMEtrexed 25 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590672 | PEMEtrexed 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590672 | PEMEtrexed 25 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590673 | Pemfexy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2590674 | pemetrexed 25 MG/ML [Pemfexy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590674 | pemetrexed 25 MG/ML [Pemfexy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590675 | Pemfexy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2590676 | pemetrexed Injectable Solution [Pemfexy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2590676 | pemetrexed Injectable Solution [Pemfexy] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590677 | Pemfexy 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590677 | Pemfexy 25 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2590677 | Pemfexy 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590677 | Pemfexy 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590678 | Physalis virginiana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590679 | Pinus cembroides pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590680 | Pinus strobus cone extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590681 | Plantago australis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590682 | Platanus occidentalis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590683 | Populus trichocarpa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590684 | Prosopis cineraria wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590685 | Ruellia simplex whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590686 | Salix lutea pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590687 | Salsola kali whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590689 | sodium chloride 0.009 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2590690 | sodium chloride 0.9 % Nasal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590690 | sodium chloride 0.9 % Nasal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590690 | sodium chloride 0.9 % Nasal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590690 | sodium chloride 0.9 % Nasal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590691 | Stenotaphrum secundatum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590692 | Suaeda maritima flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590693 | Syagrus romanzoffiana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590694 | Symphoricarpos albus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590695 | tabtoxin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590696 | Townsendia exscapa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25907 | Glutamate dehydrogenase (NADP^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25907 | Glutamate dehydrogenase (NADP^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 25907 | Glutamate dehydrogenase (NADP^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 2590728 | .beta.-carophyllene alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590729 | 1,3-beta-glucan synthase component FKS1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590740 | pramoxine hydrochloride 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590741 | hydrocortisone acetate 25 MG / pramoxine hydrochloride 18 MG Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590741 | hydrocortisone acetate 25 MG / pramoxine hydrochloride 18 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590742 | sodium laurylglucosides hydroxypropylsulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2590743 | tebentafusp | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2590744 | tebentafusp-tebn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2590745 | tebentafusp-tebn 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2590746 | tebentafusp Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2590747 | tebentafusp Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2590748 | tebentafusp-tebn 100 MCG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590748 | tebentafusp-tebn 100 MCG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590748 | tebentafusp-tebn 100 MCG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590749 | tebentafusp-tebn 0.2 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590749 | tebentafusp-tebn 0.2 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590750 | Kimmtrak | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2590751 | tebentafusp-tebn 0.2 MG/ML [Kimmtrak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2590752 | Kimmtrak Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2590753 | tebentafusp Injection [Kimmtrak] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2590754 | KIMMTRAK 100 MCG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590754 | KIMMTRAK 100 MCG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2590754 | KIMMTRAK 100 MCG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2590754 | KIMMTRAK 100 MCG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2590755 | KIMMTRAK 0.2 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590755 | KIMMTRAK 0.2 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590755 | KIMMTRAK 0.2 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2590757 | amylopectin, corn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2590759 | lauroyl - myristoyl amidopropyl amine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2590763 | Stomodine F | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2590765 | Stomodine F Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590766 | Stomodine F Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590767 | chlorhexidine Oral Gel [Stomodine F] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2590769 | chlorhexidine gluconate 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2590770 | chlorhexidine gluconate 0.2 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590770 | chlorhexidine gluconate 0.2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590770 | chlorhexidine gluconate 0.2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590771 | chlorhexidine gluconate 0.002 MG/MG [Stomodine F] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2590772 | Stomodine F 0.2 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2590772 | Stomodine F 0.2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590772 | Stomodine F 0.2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590772 | Stomodine F 0.2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25908 | Glutamate formyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 25908 | Glutamate formyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 25908 | Glutamate formyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 259081 | aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2590811 | Gas-X Total Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2590812 | calcium carbonate 750 MG / simethicone 250 MG [Gas-X Total Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2590813 | Gas-X Total Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590814 | Gas-X Total Relief Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590815 | Gas-X Total Relief Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590816 | calcium carbonate / simethicone Chewable Tablet [Gas-X Total Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2590817 | Gas-X Total Relief 750 MG / 250 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2590817 | Gas-X Total Relief 750 MG / 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590817 | Gas-X Total Relief 750 MG / 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590818 | Fem Choice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2590819 | levonorgestrel 1.5 MG [Fem Choice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 259082 | capsaicin 0.025 % / menthol 1.25 % / methylnicotinate 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259082 | capsaicin 0.025 % / menthol 1.25 % / methylnicotinate 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259082 | capsaicin 0.025 % / menthol 1.25 % / methylnicotinate 0.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590820 | Fem Choice Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590821 | Fem Choice Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2590822 | levonorgestrel Oral Tablet [Fem Choice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2590823 | Fem Choice 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590823 | Fem Choice 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590823 | Fem Choice 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259083 | carboxymethylcellulose sodium 1.5 % Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259083 | carboxymethylcellulose sodium 1.5 % Ophthalmic Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259083 | carboxymethylcellulose sodium 1.5 % Ophthalmic Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259085 | naphazoline 0.0003 MG/MG Ophthalmic Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259088 | plant stanol ester 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259089 | benzoyl peroxide 3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259089 | benzoyl peroxide 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259089 | benzoyl peroxide 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25909 | Glutamate racemase | Designated preferred name (PT) | NO | |
| RxCUI: 25909 | Glutamate racemase | Full form of descriptor (FN) | NO | |
| RxCUI: 259090 | dimethicone 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259090 | dimethicone 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259090 | dimethicone 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2590914 | Angelica anomala root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2590916 | Vanilla planifolia seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2590918 | cetylpyridinium chloride 23 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2590919 | cetylpyridinium chloride 2.3 % Concentrated Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590919 | cetylpyridinium chloride 2.3 % Concentrated Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2590919 | cetylpyridinium chloride 2.3 % Concentrated Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590920 | dimethicone 1.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2590920 | dimethicone 1.1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590922 | menthol 7 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2590922 | menthol 7 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259093 | cocoa butter 85.5 % / phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259093 | cocoa butter 85.5 % / phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259093 | cocoa butter 85.5 % / phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259094 | Zinc Oxide 26 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259094 | Zinc Oxide 26 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259094 | Zinc Oxide 26 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259097 | biotin 0.3 MG / dicalcium phosphate 27 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259099 | coenzyme Q10 30 MG / vitamin E 6 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259099 | coenzyme Q10 30 MG / vitamin E 6 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259102 | menthol 12 % / methyl salicylate 17 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259102 | menthol 12 % / methyl salicylate 17 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259102 | menthol 12 % / methyl salicylate 17 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25911 | Glutamate synthase (ferredoxin) | Designated preferred name (PT) | NO | |
| RxCUI: 25911 | Glutamate synthase (ferredoxin) | Full form of descriptor (FN) | NO | |
| RxCUI: 259111 | insulin lispro protamine / insulin lispro 75/25 Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259111 | insulin lispro protamine / insulin lispro 75/25 Injectable Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 259111 | insulin lispro protamine / insulin lispro 75/25 Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259111 | insulin lispro protamine / insulin lispro 75/25 Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259111 | insulin lispro protamine / insulin lispro 75/25 Injectable Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 259118 | ubidecarenone 30 MG / vitamin E 30 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259120 | coenzyme Q10 100 MG / vitamin E 100 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259120 | coenzyme Q10 100 MG / vitamin E 100 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259120 | coenzyme Q10 100 MG / vitamin E 100 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259121 | coenzyme Q10 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259121 | coenzyme Q10 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259121 | coenzyme Q10 30 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259122 | potassium,chelated 95 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259122 | potassium,chelated 95 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259122 | potassium,chelated 95 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259122 | potassium,chelated 95 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259126 | sennosides 167 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259126 | sennosides 167 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259126 | sennosides 167 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259128 | potassium 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259128 | potassium 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259128 | potassium 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259128 | potassium 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 25913 | Glutamate-1-semialdehyde 2,1-aminomutase | Designated preferred name (PT) | NO | |
| RxCUI: 25913 | Glutamate-1-semialdehyde 2,1-aminomutase | Full form of descriptor (FN) | NO | |
| RxCUI: 259132 | red yeast rice 600 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259132 | red yeast rice 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259133 | chondroitin sulfates 400 MG / glucosamine sulfate 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259133 | chondroitin sulfates 400 MG / glucosamine sulfate 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591356 | simethicone 10 MG/ML [Gas-X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2591357 | simethicone Oral Solution [Gas-X] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2591359 | simethicone 125 MG [Gas-X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591362 | simethicone 166 MG [Gas-X] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2591365 | Primatene with ephedrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591365 | Primatene with ephedrine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591378 | Primatene with ephedrine & guaifenesin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591378 | Primatene with ephedrine & guaifenesin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591379 | ephedrine hydrochloride 12.5 MG / guaifenesin 200 MG [Primatene with ephedrine & guaifenesin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591379 | ephedrine hydrochloride 12.5 MG / guaifenesin 200 MG [Primatene with ephedrine & guaifenesin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591380 | Primatene with ephedrine & guaifenesin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591380 | Primatene with ephedrine & guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591381 | Primatene with ephedrine & guaifenesin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591381 | Primatene with ephedrine & guaifenesin Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591382 | ephedrine / guaifenesin Oral Tablet [Primatene with ephedrine & guaifenesin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591382 | ephedrine / guaifenesin Oral Tablet [Primatene with ephedrine & guaifenesin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591386 | ephedrine hydrochloride 12.5 MG [Primatene with ephedrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591386 | ephedrine hydrochloride 12.5 MG [Primatene with ephedrine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591387 | Primatene with ephedrine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591387 | Primatene with ephedrine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591388 | Primatene with ephedrine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591388 | Primatene with ephedrine Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591389 | ephedrine Oral Tablet [Primatene with ephedrine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591389 | ephedrine Oral Tablet [Primatene with ephedrine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591391 | paliperidone palmitate 310 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591393 | paliperidone palmitate 310 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591394 | paliperidone palmitate 310 MG/ML [Invega] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591396 | paliperidone palmitate 310 MG/ML Prefilled Syringe [Invega] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591396 | paliperidone palmitate 310 MG/ML Prefilled Syringe [Invega] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591397 | paliperidone palmitate 311 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591399 | paliperidone palmitate 311 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591400 | paliperidone palmitate 311 MG/ML [Invega] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591402 | paliperidone palmitate 311 MG/ML Prefilled Syringe [Invega] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591402 | paliperidone palmitate 311 MG/ML Prefilled Syringe [Invega] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591404 | sutimlimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2591405 | Areca catechu seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591408 | Parasedge Multi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2591409 | imidacloprid 100 MG/ML / moxidectin 10 MG/ML [Parasedge Multi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2591410 | Parasedge Multi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2591411 | imidacloprid / moxidectin Topical Solution [Parasedge Multi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2591412 | PARASEDGE Multi for Cats 10 % / 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591412 | PARASEDGE Multi for Cats 10 % / 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591412 | PARASEDGE Multi for Cats 10 % / 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591413 | imidacloprid 100 MG/ML / moxidectin 25 MG/ML [Parasedge Multi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2591414 | PARASEDGE Multi for dogs 10 % / 2.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591414 | PARASEDGE Multi for dogs 10 % / 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591414 | PARASEDGE Multi for dogs 10 % / 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591415 | sutimlimab-jome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2591416 | sutimlimab-jome 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591417 | sutimlimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591418 | sutimlimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2591419 | sutimlimab-jome 1100 MG in 22 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591419 | sutimlimab-jome 1100 MG in 22 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591419 | sutimlimab-jome 1100 MG in 22 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591420 | sutimlimab-jome 50 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591420 | sutimlimab-jome 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591421 | Enjaymo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591422 | sutimlimab-jome 50 MG/ML [Enjaymo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591423 | Enjaymo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591424 | sutimlimab Injection [Enjaymo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591425 | Enjaymo 1100 MG in 22 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591425 | Enjaymo 1100 MG in 22 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591425 | Enjaymo 1100 MG in 22 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591425 | Enjaymo 1100 MG in 22 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591426 | Enjaymo 50 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591426 | Enjaymo 50 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591426 | Enjaymo 50 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591427 | vasopressin (USP) 0.2 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591428 | vasopressin (USP) 20 UNT in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591428 | vasopressin (USP) 20 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591428 | vasopressin (USP) 20 UNT in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591428 | vasopressin (USP) 20 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591429 | vasopressin (USP) 0.2 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259143 | chondroitin sulfate 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259143 | chondroitin sulfate 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591430 | vasopressin (USP) 0.2 UNT/ML [Vasostrict] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591431 | Vasostrict 20 UNT in 100 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591431 | Vasostrict 20 UNT in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591431 | Vasostrict 20 UNT in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591432 | vasopressin (USP) 0.2 UNT/ML Injection [Vasostrict] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591432 | vasopressin (USP) 0.2 UNT/ML Injection [Vasostrict] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591433 | capsaicin 0.75 MG/ML [Zostrix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591434 | Zostrix 0.075 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591434 | Zostrix 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591434 | Zostrix 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259147 | chondroitin sulfate 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259147 | chondroitin sulfate 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591476 | abrocitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2591476 | abrocitinib | Designated preferred name (PT) | YES | |
| RxCUI: 2591476 | abrocitinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2591476 | abrocitinib | Designated preferred name (PT) | YES | |
| RxCUI: 2591476 | abrocitinib | Full form of descriptor (FN) | YES | |
| RxCUI: 2591477 | abrocitinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591478 | abrocitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591478 | abrocitinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2591478 | abrocitinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2591479 | abrocitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591480 | abrocitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2591481 | abrocitinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591481 | abrocitinib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2591481 | abrocitinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591481 | abrocitinib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2591482 | Cibinqo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591483 | abrocitinib 100 MG [Cibinqo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591484 | Cibinqo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591485 | Cibinqo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591486 | abrocitinib Oral Tablet [Cibinqo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591487 | Cibinqo 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591487 | Cibinqo 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591487 | Cibinqo 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591488 | abrocitinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591489 | abrocitinib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591489 | abrocitinib 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2591489 | abrocitinib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591489 | abrocitinib 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2591490 | abrocitinib 200 MG [Cibinqo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591491 | Cibinqo 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591491 | Cibinqo 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591491 | Cibinqo 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591492 | abrocitinib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591493 | abrocitinib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591493 | abrocitinib 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2591493 | abrocitinib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591493 | abrocitinib 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2591494 | abrocitinib 50 MG [Cibinqo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591495 | Cibinqo 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591495 | Cibinqo 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591495 | Cibinqo 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591496 | daridorexant hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2591497 | daridorexant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2591498 | daridorexant 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591499 | daridorexant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 25915 | Beta-glutamylphosphate reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25915 | Beta-glutamylphosphate reductase | Designated preferred name (PT) | NO | |
| RxCUI: 25915 | Beta-glutamylphosphate reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 259150 | menthol 3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259150 | menthol 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259150 | menthol 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591500 | daridorexant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591501 | daridorexant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2591502 | daridorexant 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591502 | daridorexant 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591502 | daridorexant 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591503 | Quviviq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591504 | daridorexant 25 MG [Quviviq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591505 | Quviviq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591506 | Quviviq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591507 | daridorexant Oral Tablet [Quviviq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591508 | QUVIVIQ 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591508 | QUVIVIQ 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591508 | QUVIVIQ 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591509 | talazoparib 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 259151 | flaxseed oil 1000 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259151 | flaxseed oil 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259151 | flaxseed oil 1000 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259151 | flaxseed oil 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591510 | talazoparib 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591510 | talazoparib 0.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591510 | talazoparib 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591511 | talazoparib 0.5 MG [Talzenna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591512 | Talzenna 0.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591512 | Talzenna 0.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591512 | Talzenna 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591513 | talazoparib 0.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591516 | talazoparib 0.75 MG [Talzenna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591519 | faricimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2591519 | faricimab | Designated preferred name (PT) | YES | |
| RxCUI: 2591519 | faricimab | Full form of descriptor (FN) | YES | |
| RxCUI: 259152 | flaxseed oil 1300 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259152 | flaxseed oil 1300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259152 | flaxseed oil 1300 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259152 | flaxseed oil 1300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591520 | talazoparib 0.75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591520 | talazoparib 0.75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591520 | talazoparib 0.75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591521 | Talzenna 0.75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591521 | Talzenna 0.75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591521 | Talzenna 0.75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591522 | selenium 12 MCG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591522 | selenium 12 MCG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591522 | selenium 12 MCG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591522 | selenium 12 MCG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591522 | selenium 12 MCG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591523 | selenious acid 0.0098 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591584 | faricimab-svoa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2591585 | faricimab-svoa 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591586 | faricimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591587 | faricimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2591588 | faricimab-svoa 6 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591588 | faricimab-svoa 6 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591588 | faricimab-svoa 6 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591589 | faricimab-svoa 120 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591590 | Vabysmo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591591 | faricimab-svoa 120 MG/ML [Vabysmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591592 | Vabysmo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591593 | faricimab Injection [Vabysmo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591594 | Vabysmo 6 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591594 | Vabysmo 6 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591594 | Vabysmo 6 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591594 | Vabysmo 6 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591595 | faricimab-svoa 120 MG/ML Injection [Vabysmo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2591595 | faricimab-svoa 120 MG/ML Injection [Vabysmo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25916 | L-glutamic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 25916 | L-glutamic acid | Designated preferred name (PT) | YES | |
| RxCUI: 25916 | L-glutamic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 25916 | L-glutamic acid | Designated preferred name (PT) | YES | |
| RxCUI: 25916 | L-glutamic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25916 | L-glutamic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 2591600 | Agave atrovirens top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591601 | Amaryllis belladonna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591602 | Anacardium occidentale bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591603 | Pulsatilla montana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591604 | Zantedeschia aethiopica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591605 | Zizia aurea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591606 | Eleutherococcus senticosus root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259176 | ferrous fumarate 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259176 | ferrous fumarate 75 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 259176 | ferrous fumarate 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259176 | ferrous fumarate 75 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 259177 | guaifenesin 800 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259177 | guaifenesin 800 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259177 | guaifenesin 800 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259177 | guaifenesin 800 MG / phenylpropanolamine HCl 75 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2591785 | citalopram 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591786 | citalopram 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591786 | citalopram 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591786 | citalopram 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591787 | trolamine salicylate Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2591788 | trolamine salicylate 10 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591788 | trolamine salicylate 10 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2591788 | trolamine salicylate 10 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2591789 | Dapzura | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591790 | daptomycin 500 MG [Dapzura] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591790 | daptomycin 500 MG [Dapzura] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591791 | Dapzura Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591792 | daptomycin Injection [Dapzura] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591792 | daptomycin Injection [Dapzura] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591793 | Dapzura 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591793 | Dapzura 500 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2591793 | Dapzura 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591793 | Dapzura 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591794 | Anamirta cocculus fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591795 | Arctostaphylos tomentosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591796 | Aspidosperma quebracho-blanco root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591797 | aviscumine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591798 | Betula pubescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591799 | Bos taurus large intestine preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591800 | Ceratostigma willmottianum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591801 | mometasone furoate 0.025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2591802 | mometasone / olopatadine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2591803 | mometasone / olopatadine Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591804 | mometasone / olopatadine Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2591805 | mometasone / olopatadine Metered Dose Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2591806 | olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2591806 | olopatadine HCL 665 MCG/ACTUAT / mometasone furoate 25 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591807 | Ryaltris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2591808 | mometasone furoate 0.025 MG/ACTUAT / olopatadine hydrochloride 0.665 MG/ACTUAT [Ryaltris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2591809 | Ryaltris Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591810 | Ryaltris Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2591811 | mometasone / olopatadine Metered Dose Nasal Spray [Ryaltris] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2591812 | Ryaltris 665/25 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2591812 | Ryaltris 665/25 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591812 | Ryaltris 665/25 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2591812 | Ryaltris 665/25 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591813 | coxsackievirus A21 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591814 | Juniperus communis var. saxatilis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591815 | Mercurialis perennis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591816 | Prevotella intermedia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591817 | Sedum acre whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591818 | Simaba cedron whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2591819 | Veronicastrum virginicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259184 | guaiFENesin 600 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259184 | guaiFENesin 600 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259184 | guaiFENesin 600 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259184 | guaiFENesin 600 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 259184 | guaiFENesin 600 MG / phenylephrine HCl 20 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259191 | cyanocobalamin 0.1 MG / folic acid 0.8 MG / pyridoxine 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259191 | cyanocobalamin 0.1 MG / folic acid 0.8 MG / pyridoxine 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259191 | cyanocobalamin 0.1 MG / folic acid 0.8 MG / pyridoxine 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259191 | cyanocobalamin 0.1 MG / folic acid 0.8 MG / pyridoxine 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259193 | cascara sagrada 324 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259193 | cascara sagrada 324 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259195 | glycerin 0.3 % / propylene glycol 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259195 | glycerin 0.3 % / propylene glycol 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259195 | glycerin 0.3 % / propylene glycol 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259196 | mineral oil 20 % / petrolatum 80 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259196 | mineral oil 20 % / petrolatum 80 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259196 | mineral oil 20 % / petrolatum 80 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2591967 | dextromethorphan / doxylamine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2591968 | dextromethorphan / doxylamine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2591969 | dextromethorphan / doxylamine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2591970 | dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2591970 | dextromethorphan hydrobromide 30 MG / doxylamine succinate 12.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592 | Clofazimine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592 | Clofazimine | Designated preferred name (PT) | NO | |
| RxCUI: 2592 | Clofazimine | Full form of descriptor (FN) | NO | |
| RxCUI: 2592 | Clofazimine | Designated preferred name (PT) | NO | |
| RxCUI: 2592 | Clofazimine | Full form of descriptor (FN) | NO | |
| RxCUI: 259202 | cat hair extract 5000 BAU/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259202 | cat hair extract 5000 BAU/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259202 | cat hair extract 5000 BAU/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259203 | menthol 1 % / methyl salicylate 15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259203 | menthol 1 % / methyl salicylate 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259203 | menthol 1 % / methyl salicylate 15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2592072 | Terminalia arjuna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592077 | Amivantamab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592077 | Amivantamab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592078 | Amivantamab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592078 | Amivantamab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592079 | Amlodipine and indapamide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592079 | Amlodipine and indapamide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592080 | Amlodipine and indapamide only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592080 | Amlodipine and indapamide only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592081 | Amlodipine and lisinopril only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592081 | Amlodipine and lisinopril only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592082 | Amlodipine and lisinopril only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592082 | Amlodipine and lisinopril only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592083 | Ampicillin and cloxacillin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592083 | Ampicillin and cloxacillin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592084 | Formoterol and tiotropium only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592084 | Formoterol and tiotropium only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592085 | Formoterol and tiotropium only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592085 | Formoterol and tiotropium only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592086 | Fosfomycin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592086 | Fosfomycin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592087 | Framycetin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592087 | Framycetin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592088 | Furazolidone and metronidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592088 | Furazolidone and metronidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592089 | Furazolidone and metronidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592089 | Furazolidone and metronidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592090 | Furazolidone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592090 | Furazolidone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592091 | Piracetam only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592091 | Piracetam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592092 | Piribedil only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592092 | Piribedil only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592093 | Piribedil only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592093 | Piribedil only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592094 | Polygeline only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592094 | Polygeline only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592095 | Ponesimod only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592095 | Ponesimod only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592096 | Ponesimod only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592096 | Ponesimod only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592097 | Product containing only sulbutiamine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592097 | Product containing only sulbutiamine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592098 | Product containing only teneligliptin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592098 | Product containing only teneligliptin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592099 | Product containing only teneligliptin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592099 | Product containing only teneligliptin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592100 | Product containing only terlipressin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592100 | Product containing only terlipressin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592101 | Product containing only thiocolchicoside (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592101 | Product containing only thiocolchicoside (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592102 | Arginine and proanthocyanidin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592102 | Arginine and proanthocyanidin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592103 | Arginine and proanthocyanidin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592103 | Arginine and proanthocyanidin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592104 | Aspirin and atorvastatin and clopidogrel only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592104 | Aspirin and atorvastatin and clopidogrel only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592105 | Aspirin and atorvastatin and clopidogrel only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592105 | Aspirin and atorvastatin and clopidogrel only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592106 | Atorvastatin and ezetimibe only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592106 | Atorvastatin and ezetimibe only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592107 | Atorvastatin and ezetimibe only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592107 | Atorvastatin and ezetimibe only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592108 | Avalglucosidase alfa only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592108 | Avalglucosidase alfa only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592109 | Avalglucosidase alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592109 | Avalglucosidase alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592110 | Product containing only thiocolchicoside in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592110 | Product containing only thiocolchicoside in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592111 | Product containing only tianeptine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592111 | Product containing only tianeptine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592112 | Product containing only tianeptine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592112 | Product containing only tianeptine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592113 | Product containing only ticagrelor in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592113 | Product containing only ticagrelor in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592114 | Product containing only tigecycline in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592114 | Product containing only tigecycline in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592115 | Product containing only timolol and travoprost in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592115 | Product containing only timolol and travoprost in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592116 | Product containing only tolperisone (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592116 | Product containing only tolperisone (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592117 | Product containing only tolperisone in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592117 | Product containing only tolperisone in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592118 | Azelastine and fluticasone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592118 | Azelastine and fluticasone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592119 | Azelastine and fluticasone only product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592119 | Azelastine and fluticasone only product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592120 | Bambuterol and montelukast only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592120 | Bambuterol and montelukast only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592121 | Bambuterol and montelukast only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592121 | Bambuterol and montelukast only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592122 | Belumosudil only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592122 | Belumosudil only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592123 | Belumosudil only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592123 | Belumosudil only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592124 | Halometasone only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592124 | Halometasone only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592125 | Product containing only ubidecarenone in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592125 | Product containing only ubidecarenone in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592126 | Product containing only ustekinumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592126 | Product containing only ustekinumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592127 | Product containing only valethamate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592127 | Product containing only valethamate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592128 | Product containing only valethamate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592128 | Product containing only valethamate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592129 | Bimatoprost and timolol only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592129 | Bimatoprost and timolol only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259213 | glucosamine 340 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259213 | glucosamine 340 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592130 | Brincidofovir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592130 | Brincidofovir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592131 | Brincidofovir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592131 | Brincidofovir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592132 | Bromelains and diclofenac and rutoside and trypsin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592132 | Bromelains and diclofenac and rutoside and trypsin only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592132 | Bromelains and diclofenac and rutoside and trypsin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592133 | Bromelains and diclofenac and rutoside and trypsin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592133 | Bromelains and diclofenac and rutoside and trypsin only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592133 | Bromelains and diclofenac and rutoside and trypsin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592134 | Hyaluronic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592134 | Hyaluronic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592135 | Product containing only rabeprazole in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592135 | Product containing only rabeprazole in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592136 | Product containing only racecadotril in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592136 | Product containing only racecadotril in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592137 | Product containing only rebamipide (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592137 | Product containing only rebamipide (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592138 | Product containing only rebamipide in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592138 | Product containing only rebamipide in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592139 | Product containing only remogliflozin etabonate (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592139 | Product containing only remogliflozin etabonate (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592140 | Product containing only remogliflozin etabonate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592140 | Product containing only remogliflozin etabonate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592141 | Product containing only viloxazine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592141 | Product containing only viloxazine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592142 | Product containing only voglibose (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592142 | Product containing only voglibose (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592143 | Camostat only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592143 | Camostat only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592144 | Camostat only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592144 | Camostat only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592145 | Casimersen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592145 | Casimersen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592146 | Infigratinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592146 | Infigratinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592147 | Infigratinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592147 | Infigratinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592148 | Product containing only rupatadine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592148 | Product containing only rupatadine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592149 | Product containing only rupatadine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592149 | Product containing only rupatadine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592150 | Product containing only samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592150 | Product containing only samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592151 | Product containing only saroglitazar (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592151 | Product containing only saroglitazar (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592152 | Product containing only saroglitazar in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592152 | Product containing only saroglitazar in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592153 | Product containing only voglibose in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592153 | Product containing only voglibose in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592154 | Product containing only zanamivir in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592154 | Product containing only zanamivir in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592155 | Casimersen only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592155 | Casimersen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592156 | Chlorhexidine and metronidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592156 | Chlorhexidine and metronidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592157 | Chlorhexidine and metronidazole only product in dental dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592157 | Chlorhexidine and metronidazole only product in dental dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592158 | Iodixanol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592158 | Iodixanol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592159 | Iomeprol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592159 | Iomeprol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259216 | poractant alfa 80 MG/ML Intratracheal Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259216 | poractant alfa 80 MG/ML Intratracheal Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259216 | poractant alfa 80 MG/ML Intratracheal Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 259216 | poractant alfa 80 MG/ML Intratracheal Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2592160 | Iopamidol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592160 | Iopamidol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592161 | Iopromide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592161 | Iopromide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592162 | Ipratropium and levosalbutamol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592162 | Ipratropium and levosalbutamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592162 | Ipratropium and levosalbutamol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592163 | Ipratropium and levosalbutamol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592163 | Ipratropium and levosalbutamol only product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592163 | Ipratropium and levosalbutamol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592166 | Chlortalidone and telmisartan only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592166 | Chlortalidone and telmisartan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592166 | Chlortalidone and telmisartan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592167 | Chlortalidone and telmisartan only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592167 | Chlortalidone and telmisartan only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592167 | Chlortalidone and telmisartan only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592168 | Cilnidipine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592168 | Cilnidipine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592169 | Cilnidipine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592169 | Cilnidipine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592170 | Citicoline only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592170 | Citicoline only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592171 | Citicoline only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592171 | Citicoline only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592172 | Clobetasol and gentamicin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592172 | Clobetasol and gentamicin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592173 | Clobetasol and gentamicin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592173 | Clobetasol and gentamicin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592174 | Itolizumab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592174 | Itolizumab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592175 | Itolizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592175 | Itolizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592176 | Lacosamide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592176 | Lacosamide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592177 | Levamisole and mebendazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592177 | Levamisole and mebendazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592178 | Levamisole and mebendazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592178 | Levamisole and mebendazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592179 | Clonazepam and escitalopram only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592179 | Clonazepam and escitalopram only product | Full form of descriptor (FN) | NO | |
| RxCUI: 259218 | levonorgestrel 0.75 MG 2 Count Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259218 | levonorgestrel 0.75 MG 2 Count Oral Tablet Pack | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259218 | levonorgestrel 0.75 MG 2 Count Oral Tablet Pack | Designated preferred name (PT) | YES | |
| RxCUI: 259218 | levonorgestrel 0.75 MG 2 Count Oral Tablet Pack | Full form of descriptor (FN) | YES | |
| RxCUI: 2592180 | Clonazepam and escitalopram only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592180 | Clonazepam and escitalopram only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592181 | Coal tar and ketoconazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592181 | Coal tar and ketoconazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592182 | Coal tar and ketoconazole only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592182 | Coal tar and ketoconazole only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592183 | Coal tar and salicylic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592183 | Coal tar and salicylic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592184 | Coal tar and salicylic acid only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592184 | Coal tar and salicylic acid only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592185 | Levosulpiride only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592185 | Levosulpiride only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592186 | Levosulpiride only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592186 | Levosulpiride only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592187 | Lidocaine and metronidazole and sucralfate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592187 | Lidocaine and metronidazole and sucralfate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592188 | Lidocaine and metronidazole and sucralfate only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592188 | Lidocaine and metronidazole and sucralfate only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592189 | Lidocaine and nifedipine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592189 | Lidocaine and nifedipine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592190 | Lidocaine and nifedipine only product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592190 | Lidocaine and nifedipine only product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592191 | Light liquid paraffin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592191 | Light liquid paraffin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592192 | Light liquid paraffin only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592192 | Light liquid paraffin only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592193 | Loperamide only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592193 | Loperamide only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592194 | Daptomycin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592194 | Daptomycin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592195 | Darunavir and ritonavir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592195 | Darunavir and ritonavir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592196 | Darunavir and ritonavir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592196 | Darunavir and ritonavir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592197 | Lysine only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592197 | Lysine only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592198 | Magnesium hydroxide and mineral oil only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592198 | Magnesium hydroxide and mineral oil only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592199 | Mecobalamin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592199 | Mecobalamin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592200 | Mephentermine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592200 | Mephentermine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592201 | Mephentermine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592201 | Mephentermine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592202 | Dexamethasone and ofloxacin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592202 | Dexamethasone and ofloxacin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592203 | Dexamethasone and ofloxacin only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592203 | Dexamethasone and ofloxacin only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592204 | Dexmethylphenidate and serdexmethylphenidate only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592204 | Dexmethylphenidate and serdexmethylphenidate only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592205 | Dexmethylphenidate and serdexmethylphenidate only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592205 | Dexmethylphenidate and serdexmethylphenidate only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592206 | Dexrabeprazole and domperidone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592206 | Dexrabeprazole and domperidone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592207 | Dexrabeprazole and domperidone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592207 | Dexrabeprazole and domperidone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592208 | Diacerein and glucosamine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592208 | Diacerein and glucosamine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592209 | Diacerein and glucosamine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592209 | Diacerein and glucosamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259221 | glucosamine sulfate 500 MG / potassium 62.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259221 | glucosamine sulfate 500 MG / potassium 62.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259221 | glucosamine sulfate 500 MG / potassium 62.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259221 | glucosamine sulfate 500 MG / potassium 62.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592210 | Diltiazem only product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592210 | Diltiazem only product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592211 | Metformin and vildagliptin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592211 | Metformin and vildagliptin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592212 | Metformin and vildagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592212 | Metformin and vildagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592213 | Domperidone and omeprazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592213 | Domperidone and omeprazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592214 | Domperidone and omeprazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592214 | Domperidone and omeprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592215 | Domperidone and pantoprazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592215 | Domperidone and pantoprazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592216 | Domperidone and pantoprazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592216 | Domperidone and pantoprazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592217 | Domperidone only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592217 | Domperidone only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592218 | Doxofylline only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592218 | Doxofylline only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592219 | Doxofylline only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592219 | Doxofylline only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592220 | Drospirenone and estetrol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592220 | Drospirenone and estetrol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592221 | Drospirenone and estetrol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592221 | Drospirenone and estetrol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592222 | Drotaverine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592222 | Drotaverine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592223 | Drotaverine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592223 | Drotaverine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592224 | Dutasteride and silodosin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592224 | Dutasteride and silodosin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592225 | Dutasteride and silodosin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592225 | Dutasteride and silodosin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592226 | Eberconazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592226 | Eberconazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592227 | Mosapride only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592227 | Mosapride only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592228 | Mosapride only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592228 | Mosapride only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592229 | Eberconazole only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592229 | Eberconazole only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259223 | sennosides, USP 25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592230 | Eptacog alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592230 | Eptacog alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592231 | Norfloxacin and tinidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592231 | Norfloxacin and tinidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592232 | Norfloxacin and tinidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592232 | Norfloxacin and tinidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592233 | Odevixibat only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592233 | Odevixibat only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592234 | Odevixibat only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592234 | Odevixibat only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592235 | Ofloxacin and ornidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592235 | Ofloxacin and ornidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592236 | Ofloxacin and ornidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592236 | Ofloxacin and ornidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592237 | Ofloxacin and tinidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592237 | Ofloxacin and tinidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592238 | Ofloxacin and tinidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592238 | Ofloxacin and tinidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592239 | Omalizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592239 | Omalizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259224 | zonisamide 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259224 | zonisamide 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592240 | Etamsylate and tranexamic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592240 | Etamsylate and tranexamic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592241 | Etamsylate and tranexamic acid only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592241 | Etamsylate and tranexamic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592242 | Etizolam only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592242 | Etizolam only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592243 | Etizolam only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592243 | Etizolam only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592244 | Faropenem only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592244 | Faropenem only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592245 | Faropenem only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592245 | Faropenem only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592246 | Favipiravir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592246 | Favipiravir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592247 | Favipiravir only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592247 | Favipiravir only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592248 | Fenofibrate and rosuvastatin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592248 | Fenofibrate and rosuvastatin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592249 | Opipramol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592249 | Opipramol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592250 | Opipramol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592250 | Opipramol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592251 | Ormeloxifene only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592251 | Ormeloxifene only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592252 | Ormeloxifene only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592252 | Ormeloxifene only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592253 | Oxycodone only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592253 | Oxycodone only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592254 | Paliperidone only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592254 | Paliperidone only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592255 | Product containing only sildenafil in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592255 | Product containing only sildenafil in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592256 | Fenofibrate and rosuvastatin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592256 | Fenofibrate and rosuvastatin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592257 | Ferric derisomaltose only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592257 | Ferric derisomaltose only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592258 | Ferric derisomaltose only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592258 | Ferric derisomaltose only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592259 | Fexinidazole only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592259 | Fexinidazole only product | Full form of descriptor (FN) | NO | |
| RxCUI: 259226 | soy isoflavones 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259226 | soy isoflavones 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259226 | soy isoflavones 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2592260 | Fexinidazole only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592260 | Fexinidazole only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592261 | Finasteride and tamsulosin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592261 | Finasteride and tamsulosin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592262 | Finasteride and tamsulosin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592262 | Finasteride and tamsulosin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592263 | Finerenone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592263 | Finerenone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592264 | Finerenone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592264 | Finerenone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592265 | Fluconazole only product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592265 | Fluconazole only product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592266 | Flunarizine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592266 | Flunarizine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592267 | Flunarizine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592267 | Flunarizine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592268 | Pegcetacoplan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592268 | Pegcetacoplan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592269 | Pegcetacoplan only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592269 | Pegcetacoplan only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592270 | Peginterferon beta-1a only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592270 | Peginterferon beta-1a only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592271 | Pheniramine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592271 | Pheniramine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592272 | Pheniramine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592272 | Pheniramine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592273 | Pimecrolimus only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592273 | Pimecrolimus only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592274 | Product containing only sotorasib (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592274 | Product containing only sotorasib (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2592275 | Product containing only sotorasib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592275 | Product containing only sotorasib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592276 | Spironolactone and torasemide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592276 | Spironolactone and torasemide only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592276 | Spironolactone and torasemide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592277 | Spironolactone and torasemide only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592277 | Spironolactone and torasemide only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592277 | Spironolactone and torasemide only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592278 | Ademetionine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592278 | Ademetionine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592279 | Ambroxol and loratadine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592279 | Ambroxol and loratadine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592280 | Ambroxol and loratadine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592280 | Ambroxol and loratadine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592281 | Alfuzosin and dutasteride only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592281 | Alfuzosin and dutasteride only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592282 | Allylestrenol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592282 | Allylestrenol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592283 | Alpha/beta-arteether only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592283 | Alpha/beta-arteether only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592284 | Alpha/beta-arteether only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592284 | Alpha/beta-arteether only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592285 | Aducanumab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592285 | Aducanumab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592286 | Aducanumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592286 | Aducanumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592287 | Albendazole and ivermectin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592287 | Albendazole and ivermectin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592288 | Ambroxol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592288 | Ambroxol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592289 | Ambroxol only product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592289 | Ambroxol only product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592290 | Albendazole and ivermectin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592290 | Albendazole and ivermectin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592291 | Alfuzosin and dutasteride only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592291 | Alfuzosin and dutasteride only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592292 | Ibuprofen and paracetamol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592292 | Ibuprofen and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592292 | Ibuprofen and paracetamol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592293 | Ibuprofen and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592293 | Ibuprofen and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592293 | Ibuprofen and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592294 | Lornoxicam and paracetamol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592294 | Lornoxicam and paracetamol only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592294 | Lornoxicam and paracetamol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592295 | Lornoxicam and paracetamol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592295 | Lornoxicam and paracetamol only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592295 | Lornoxicam and paracetamol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592296 | Acetylcysteine and ambroxol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2592296 | Acetylcysteine and ambroxol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592297 | Acetylcysteine and ambroxol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592297 | Acetylcysteine and ambroxol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259233 | clindamycin phosphate 100 MG Vaginal Insert | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259233 | clindamycin phosphate 100 MG Vaginal Insert | Designated preferred name (PT) | YES | |
| RxCUI: 259233 | clindamycin phosphate 100 MG Vaginal Insert | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259233 | clindamycin phosphate 100 MG Vaginal Insert | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259233 | clindamycin phosphate 100 MG Vaginal Insert | Full form of descriptor (FN) | YES | |
| RxCUI: 2592360 | bebtelovimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592360 | bebtelovimab | Designated preferred name (PT) | YES | |
| RxCUI: 2592360 | bebtelovimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2592360 | bebtelovimab | Designated preferred name (PT) | YES | |
| RxCUI: 2592360 | bebtelovimab | Full form of descriptor (FN) | YES | |
| RxCUI: 2592361 | bebtelovimab 87.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592362 | bebtelovimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2592362 | bebtelovimab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 2592362 | bebtelovimab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2592363 | bebtelovimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2592364 | bebtelovimab 175 MG in 2 ML Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2592364 | bebtelovimab 175 MG in 2 ML Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2592364 | bebtelovimab 175 MG in 2 ML Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592365 | bebtelovimab 87.5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592365 | bebtelovimab 87.5 MG/ML Injection | Designated preferred name (PT) | NO | |
| RxCUI: 2592365 | bebtelovimab 87.5 MG/ML Injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2592366 | Lornoxicam- and paracetamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592366 | Lornoxicam- and paracetamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592366 | Lornoxicam- and paracetamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592367 | Lornoxicam- and paracetamol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592367 | Lornoxicam- and paracetamol-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592367 | Lornoxicam- and paracetamol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592368 | Acetylcysteine- and ambroxol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592368 | Acetylcysteine- and ambroxol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592369 | Acetylcysteine- and ambroxol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592369 | Acetylcysteine- and ambroxol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259237 | chondroitin sulfates 200 MG / glucosamine sulfate 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259237 | chondroitin sulfates 200 MG / glucosamine sulfate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592370 | Albendazole- and ivermectin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592370 | Albendazole- and ivermectin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592371 | Albendazole- and ivermectin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592371 | Albendazole- and ivermectin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592372 | Alfuzosin- and dutasteride-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592372 | Alfuzosin- and dutasteride-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592373 | Alfuzosin- and dutasteride-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592373 | Alfuzosin- and dutasteride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592374 | Alpha/beta-arteether-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592374 | Alpha/beta-arteether-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592375 | Alpha/beta-arteether-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592375 | Alpha/beta-arteether-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592376 | Ambroxol- and loratadine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592376 | Ambroxol- and loratadine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592377 | Ambroxol- and loratadine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592377 | Ambroxol- and loratadine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259239 | methylsulfonylmethane 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259239 | methylsulfonylmethane 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 25924 | Glutamin-(asparagin-)ase | Designated preferred name (PT) | NO | |
| RxCUI: 25924 | Glutamin-(asparagin-)ase | Full form of descriptor (FN) | NO | |
| RxCUI: 259240 | magnesium oxide 600 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259240 | magnesium oxide 600 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259241 | titanium dioxide 3 % / zinc oxide 8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259241 | titanium dioxide 3 % / zinc oxide 8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259241 | titanium dioxide 3 % / zinc oxide 8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259241 | titanium dioxide 3 % / zinc oxide 8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259249 | menthol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259249 | menthol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259249 | menthol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592500 | sodium chloride 37.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592502 | sodium chloride 37.5 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592505 | sodium chloride 30 MG/ML [Simply Saline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592507 | sodium chloride 30 MG/ML [ENTsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592511 | sodium chloride 26.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592513 | sodium chloride 26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592515 | sodium chloride 26 MG/ML [Nasal Asalt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592517 | sodium chloride 26 MG/ML [Breathe the Sea] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592519 | sodium chloride 21.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592521 | sodium chloride 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592523 | sodium chloride 21 MG/ML [SaltAire] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592525 | sodium chloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592527 | sodium chloride 11.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592529 | sodium chloride 11.25 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592532 | sodium chloride 9 MG/ML [Simply Saline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592534 | sodium chloride 9 MG/ML [Breathe Free Saline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592537 | sodium chloride 9 MG/ML [Nasadrops] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592539 | sodium chloride 9 MG/ML [Cleanoz Saline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592541 | sodium chloride 8.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592544 | sodium chloride 6.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592546 | sodium chloride 6.9 MG/ML [Mycinaire] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592548 | sodium chloride 6.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 259255 | atorvastatin calcium 80 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 259255 | atorvastatin calcium 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259255 | atorvastatin calcium 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259255 | atorvastatin calcium 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259255 | atorvastatin calcium 80 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2592550 | sodium chloride 6.5 MG/ML [Sea Soft] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592552 | sodium chloride 6.5 MG/ML [Sea Mist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592554 | sodium chloride 6.5 MG/ML [Ocean brand of sodium chloride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592556 | sodium chloride 6.5 MG/ML [Na-zone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592558 | sodium chloride 6.5 MG/ML [Marine Mist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 259256 | benzoyl peroxide 7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259256 | benzoyl peroxide 7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259256 | benzoyl peroxide 7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592560 | sodium chloride 6.5 MG/ML [Little Noses] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592562 | sodium chloride 6.5 MG/ML [Humist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592564 | sodium chloride 6.5 MG/ML [Deep Sea] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592566 | sodium chloride 6.5 MG/ML [Breathe Free Saline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592568 | sodium chloride 6.5 MG/ML [Ayr Saline Nasal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592570 | sodium chloride 6.5 MG/ML [Altamist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592573 | sodium chloride 6.5 MG/ML [Nasal Moist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592578 | sodium chloride 5 MG/ML [Pediamist] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 259258 | S-adenosylmethionine 200 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259258 | S-adenosylmethionine 200 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259258 | S-adenosylmethionine 200 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592582 | sodium chloride 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592584 | sodium chloride 4 MG/ML [Salinex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2592589 | sodium chloride 2 MG/ML [Rhinaris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592591 | sodium chloride 0.011 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2592593 | sodium chloride 0.011 MG/MG [ENTsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592595 | sodium chloride 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592597 | sodium chloride 0.002 MG/MG [Rhinaris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 25926 | Glutamine phenylacetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 25926 | Glutamine phenylacetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 259260 | button mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592605 | Amlodipine- and indapamide-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592605 | Amlodipine- and indapamide-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592606 | Amlodipine- and indapamide-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592606 | Amlodipine- and indapamide-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592607 | Amlodipine- and lisinopril-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592607 | Amlodipine- and lisinopril-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592608 | Amlodipine- and lisinopril-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592608 | Amlodipine- and lisinopril-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592609 | Ampicillin- and cloxacillin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592609 | Ampicillin- and cloxacillin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592610 | Arginine- and proanthocyanidin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592610 | Arginine- and proanthocyanidin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592611 | Arginine- and proanthocyanidin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592611 | Arginine- and proanthocyanidin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592612 | Aspirin- and atorvastatin- and clopidogrel-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592612 | Aspirin- and atorvastatin- and clopidogrel-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592613 | Aspirin- and atorvastatin- and clopidogrel-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592613 | Aspirin- and atorvastatin- and clopidogrel-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592615 | Achillea millefolium seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592616 | Astragalus americanus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259262 | dextromethorphan tannate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2592621 | Elettaria ensal whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592623 | Jacobaea maritima leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592624 | Nasturtium officinale leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592625 | Oenanthe crocata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592626 | Pimpinella saxifraga whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592629 | sodium isostearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259263 | estrogenic substances | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259264 | Ganirelix acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259264 | Ganirelix acetate | Designated preferred name (PT) | YES | |
| RxCUI: 259264 | Ganirelix acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 2592640 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lidozen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2592641 | LidozenPatch 4 % / 1 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2592641 | LidozenPatch 4 % / 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592641 | LidozenPatch 4 % / 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2592643 | dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2592643 | dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2592643 | dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592644 | Ambroxol-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592644 | Ambroxol-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592645 | sodium chloride 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2592649 | glycerin 30 MG/ML / sodium chloride 7.5 MG/ML [Pretz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 259265 | Ginkgo biloba leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592652 | Bambuterol- and montelukast-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592652 | Bambuterol- and montelukast-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592653 | Bambuterol- and montelukast-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592653 | Bambuterol- and montelukast-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592654 | Bimatoprost- and timolol-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592654 | Bimatoprost- and timolol-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592656 | Brincidofovir-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592656 | Brincidofovir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592657 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592657 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592657 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592658 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592658 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592658 | Bromelains- and diclofenac- and rutoside- and trypsin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259266 | Hops extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259266 | Hops extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259266 | Hops extract | Designated preferred name (PT) | YES | |
| RxCUI: 259266 | Hops extract | Full form of descriptor (FN) | YES | |
| RxCUI: 2592662 | Camostat-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592662 | Camostat-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592663 | Chlorhexidine- and metronidazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592663 | Chlorhexidine- and metronidazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592664 | Chlorhexidine- and metronidazole-containing product in dental dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592664 | Chlorhexidine- and metronidazole-containing product in dental dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592667 | Chlortalidone- and telmisartan-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592667 | Chlortalidone- and telmisartan-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592667 | Chlortalidone- and telmisartan-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592668 | Chlortalidone- and telmisartan-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592668 | Chlortalidone- and telmisartan-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592668 | Chlortalidone- and telmisartan-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592676 | Cilnidipine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592676 | Cilnidipine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592677 | Clobetasol- and gentamicin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592677 | Clobetasol- and gentamicin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592678 | Clobetasol- and gentamicin-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592678 | Clobetasol- and gentamicin-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259268 | indium In-111 pentetate disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2592680 | Clonazepam- and escitalopram-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592680 | Clonazepam- and escitalopram-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592681 | Clonazepam- and escitalopram-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592681 | Clonazepam- and escitalopram-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592682 | Coal tar- and ketoconazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592682 | Coal tar- and ketoconazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592683 | Coal tar- and ketoconazole-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592683 | Coal tar- and ketoconazole-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592684 | Darunavir- and ritonavir-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592684 | Darunavir- and ritonavir-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592685 | Darunavir- and ritonavir-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592685 | Darunavir- and ritonavir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592686 | Dexamethasone- and ofloxacin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592686 | Dexamethasone- and ofloxacin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592687 | Dexamethasone- and ofloxacin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592687 | Dexamethasone- and ofloxacin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592688 | Dexrabeprazole- and domperidone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592688 | Dexrabeprazole- and domperidone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592689 | Dexrabeprazole- and domperidone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592689 | Dexrabeprazole- and domperidone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592690 | Diacerein- and glucosamine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592690 | Diacerein- and glucosamine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592691 | Diacerein- and glucosamine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592691 | Diacerein- and glucosamine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592692 | Diltiazem-containing product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592692 | Diltiazem-containing product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592693 | Domperidone- and omeprazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592693 | Domperidone- and omeprazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592694 | Domperidone- and omeprazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592694 | Domperidone- and omeprazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592695 | Domperidone- and pantoprazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592695 | Domperidone- and pantoprazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592696 | Domperidone- and pantoprazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592696 | Domperidone- and pantoprazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592697 | Domperidone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592697 | Domperidone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592699 | Doxofylline-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592699 | Doxofylline-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592700 | Drotaverine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592700 | Drotaverine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592701 | Dutasteride- and silodosin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592701 | Dutasteride- and silodosin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592702 | Dutasteride- and silodosin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592702 | Dutasteride- and silodosin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592704 | Eberconazole-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592704 | Eberconazole-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592705 | Eptacog alfa-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592705 | Eptacog alfa-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592707 | Etamsylate- and tranexamic acid-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592707 | Etamsylate- and tranexamic acid-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592708 | Etamsylate- and tranexamic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592708 | Etamsylate- and tranexamic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592711 | Etizolam-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592711 | Etizolam-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592713 | Faropenem-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592713 | Faropenem-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592715 | Favipiravir-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592715 | Favipiravir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592716 | Fenofibrate- and rosuvastatin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592716 | Fenofibrate- and rosuvastatin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592717 | Fenofibrate- and rosuvastatin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592717 | Fenofibrate- and rosuvastatin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592719 | Alendronic acid (as alendronate sodium) 7 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2592719 | Alendronic acid (as alendronate sodium) 7 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2592720 | Finasteride- and tamsulosin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592720 | Finasteride- and tamsulosin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592721 | Finasteride- and tamsulosin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592721 | Finasteride- and tamsulosin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592722 | Fluconazole-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592722 | Fluconazole-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592723 | Formoterol- and tiotropium-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592723 | Formoterol- and tiotropium-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592724 | Formoterol- and tiotropium-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592724 | Formoterol- and tiotropium-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592725 | Furazolidone- and metronidazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592725 | Furazolidone- and metronidazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592726 | Alpha/beta-arteether 75 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2592726 | Alpha/beta-arteether 75 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2592727 | Furazolidone- and metronidazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592727 | Furazolidone- and metronidazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592729 | Iomeprol-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592729 | Iomeprol-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592730 | Iopromide-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592730 | Iopromide-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592731 | Ipratropium- and levosalbutamol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592731 | Ipratropium- and levosalbutamol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592731 | Ipratropium- and levosalbutamol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592732 | Ipratropium- and levosalbutamol-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592732 | Ipratropium- and levosalbutamol-containing product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592732 | Ipratropium- and levosalbutamol-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592736 | Itolizumab-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592736 | Itolizumab-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592737 | Levamisole- and mebendazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592737 | Levamisole- and mebendazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592738 | Levamisole- and mebendazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592738 | Levamisole- and mebendazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259274 | Silybum marianum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259274 | Silybum marianum seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592740 | Levosulpiride-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592740 | Levosulpiride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592741 | Lidocaine- and metronidazole- and sucralfate-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592741 | Lidocaine- and metronidazole- and sucralfate-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592742 | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592742 | Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592743 | Lidocaine- and nifedipine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592743 | Lidocaine- and nifedipine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592744 | Lidocaine- and nifedipine-containing product in rectal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592744 | Lidocaine- and nifedipine-containing product in rectal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592745 | Loperamide-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592745 | Loperamide-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592748 | Lysine-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592748 | Lysine-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259275 | Oseltamivir phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259275 | Oseltamivir phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 259275 | Oseltamivir phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 259276 | pine bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259277 | potassium,chelated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259280 | Tenecteplase | Full form of descriptor (FN) | YES | |
| RxCUI: 259280 | Tenecteplase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259280 | Tenecteplase | Designated preferred name (PT) | YES | |
| RxCUI: 259280 | Tenecteplase | Full form of descriptor (FN) | YES | |
| RxCUI: 259280 | Tenecteplase | Designated preferred name (PT) | YES | |
| RxCUI: 259281 | Trimethoprim hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259281 | Trimethoprim hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 259281 | Trimethoprim hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 259282 | 133-Xe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259282 | 133-Xe | Full form of descriptor (FN) | YES | |
| RxCUI: 259282 | 133-Xe | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259282 | 133-Xe | Designated preferred name (PT) | YES | |
| RxCUI: 259282 | 133-Xe | Full form of descriptor (FN) | YES | |
| RxCUI: 259282 | 133-Xe | Designated preferred name (PT) | YES | |
| RxCUI: 259283 | Yucca | Designated preferred name (PT) | NO | |
| RxCUI: 259283 | Yucca | Full form of descriptor (FN) | NO | |
| RxCUI: 259283 | Yucca | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592848 | Metformin- and vildagliptin-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592848 | Metformin- and vildagliptin-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592849 | Metformin- and vildagliptin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592849 | Metformin- and vildagliptin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 259285 | calcium carbonate 500 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592850 | Norfloxacin- and tinidazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592850 | Norfloxacin- and tinidazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592851 | Norfloxacin- and tinidazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592851 | Norfloxacin- and tinidazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592852 | Ofloxacin- and ornidazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592852 | Ofloxacin- and ornidazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592853 | Ofloxacin- and ornidazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592853 | Ofloxacin- and ornidazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592854 | Ofloxacin- and tinidazole-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592854 | Ofloxacin- and tinidazole-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592855 | Ofloxacin- and tinidazole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592855 | Ofloxacin- and tinidazole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592857 | Ormeloxifene-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592857 | Ormeloxifene-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592858 | Oxycodone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592858 | Oxycodone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592860 | Pheniramine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592860 | Pheniramine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592862 | Product containing rabeprazole in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592862 | Product containing rabeprazole in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592865 | Product containing rebamipide in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592865 | Product containing rebamipide in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592868 | Product containing remogliflozin etabonate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592868 | Product containing remogliflozin etabonate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 259287 | vitamin A 0.375 MG (1250 UNT) / cholecalciferol 135 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259287 | vitamin A 0.375 MG (1250 UNT) / cholecalciferol 135 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259287 | vitamin A 0.375 MG (1250 UNT) / cholecalciferol 135 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2592870 | Product containing rupatadine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592870 | Product containing rupatadine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592871 | Product containing samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592871 | Product containing samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592873 | Product containing saroglitazar in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592873 | Product containing saroglitazar in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592874 | Spironolactone- and torasemide-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2592874 | Spironolactone- and torasemide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592874 | Spironolactone- and torasemide-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2592875 | Spironolactone- and torasemide-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2592875 | Spironolactone- and torasemide-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592875 | Spironolactone- and torasemide-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2592879 | Product containing teneligliptin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592879 | Product containing teneligliptin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592880 | Product containing ticagrelor in oromucosal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592880 | Product containing ticagrelor in oromucosal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592881 | Product containing timolol and travoprost in ocular dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592881 | Product containing timolol and travoprost in ocular dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592883 | Product containing valethamate in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592883 | Product containing valethamate in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592885 | Product containing voglibose in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592885 | Product containing voglibose in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592886 | Product containing zanamivir in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2592886 | Product containing zanamivir in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2592887 | Paracetamol 1 g prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592887 | Paracetamol 1 g prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592887 | Paracetamol 1 g prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592888 | Lornoxicam 4 mg and paracetamol 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592888 | Lornoxicam 4 mg and paracetamol 500 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592888 | Lornoxicam 4 mg and paracetamol 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592889 | Acetylcysteine 300 mg and ambroxol hydrochloride 30 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592889 | Acetylcysteine 300 mg and ambroxol hydrochloride 30 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 259289 | glycolic acid 12 % / pyruvic acid 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259289 | glycolic acid 12 % / pyruvic acid 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259289 | glycolic acid 12 % / pyruvic acid 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592890 | Aciclovir 1.2 g prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592890 | Aciclovir 1.2 g prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592890 | Aciclovir 1.2 g prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592891 | Albendazole 400 mg and ivermectin 12 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592891 | Albendazole 400 mg and ivermectin 12 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592892 | Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592892 | Alfuzosin hydrochloride 10 mg and dutasteride 500 microgram prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592893 | Ambroxol acefyllinate 100 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592893 | Ambroxol acefyllinate 100 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592894 | Ambroxol acefyllinate 100 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592894 | Ambroxol acefyllinate 100 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592895 | Ambroxol hydrochloride 30 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592895 | Ambroxol hydrochloride 30 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592896 | Ambroxol hydrochloride 60 mg and loratadine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592896 | Ambroxol hydrochloride 60 mg and loratadine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592897 | Ambroxol hydrochloride 75 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592897 | Ambroxol hydrochloride 75 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 25929 | Glutaminase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25929 | Glutaminase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25929 | Glutaminase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25929 | Glutaminase II | Designated preferred name (PT) | NO | |
| RxCUI: 25929 | Glutaminase II | Full form of descriptor (FN) | NO | |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259290 | quinupristin / dalfopristin 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592900 | Amlodipine (as amlodipine besilate) 10 mg and lisinopril 20 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592900 | Amlodipine (as amlodipine besilate) 10 mg and lisinopril 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592900 | Amlodipine (as amlodipine besilate) 10 mg and lisinopril 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592901 | Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592901 | Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592901 | Amlodipine (as amlodipine besilate) 2.5 mg and indapamide 1.5 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592902 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592902 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592902 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592903 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 20 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592903 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592903 | Amlodipine (as amlodipine besilate) 5 mg and lisinopril 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592905 | Amoxicillin 125 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2592905 | Amoxicillin 125 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592905 | Amoxicillin 125 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2592906 | Aspirin 150 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592906 | Aspirin 150 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592907 | Aspirin 50 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592907 | Aspirin 50 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592908 | Aspirin 75 mg and atorvastatin (as atorvastatin calcium) 20 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592908 | Aspirin 75 mg and atorvastatin (as atorvastatin calcium) 20 mg and clopidogrel (as clopidogrel bisulfate) 75 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592909 | Atomoxetine (as atomoxetine hydrochloride) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592909 | Atomoxetine (as atomoxetine hydrochloride) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592910 | Bambuterol hydrochloride 10 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592910 | Bambuterol hydrochloride 10 mg and montelukast (as montelukast sodium) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592911 | Benzthiazide 25 mg and triamterene 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592911 | Benzthiazide 25 mg and triamterene 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592912 | Biperiden hydrochloride 4 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592912 | Biperiden hydrochloride 4 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592914 | Bromelains 90 mg and diclofenac sodium 50 mg and rutoside trihydrate 100 mg and trypsin 48 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592914 | Bromelains 90 mg and diclofenac sodium 50 mg and rutoside trihydrate 100 mg and trypsin 48 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592914 | Bromelains 90 mg and diclofenac sodium 50 mg and rutoside trihydrate 100 mg and trypsin 48 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592915 | Carvedilol phosphate 10 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592915 | Carvedilol phosphate 10 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592916 | Carvedilol phosphate 20 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592916 | Carvedilol phosphate 20 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592917 | Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592917 | Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592917 | Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592918 | Chlortalidone 12.5 mg and telmisartan 40 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592918 | Chlortalidone 12.5 mg and telmisartan 40 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592918 | Chlortalidone 12.5 mg and telmisartan 40 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592919 | Chlortalidone 6.25 mg and telmisartan 40 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592919 | Chlortalidone 6.25 mg and telmisartan 40 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592919 | Chlortalidone 6.25 mg and telmisartan 40 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592920 | Chlortalidone 6.25 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592920 | Chlortalidone 6.25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592920 | Chlortalidone 6.25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592921 | Cilnidipine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592921 | Cilnidipine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592922 | Cilnidipine 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592922 | Cilnidipine 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592923 | Cilnidipine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592923 | Cilnidipine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592924 | Clomifene citrate 25 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592924 | Clomifene citrate 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592924 | Clomifene citrate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592925 | Clonazepam 500 microgram and escitalopram (as escitalopram oxalate) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592925 | Clonazepam 500 microgram and escitalopram (as escitalopram oxalate) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592926 | Conjugated estrogen 1.25 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592926 | Conjugated estrogen 1.25 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592927 | Conjugated estrogen 625 microgram prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592927 | Conjugated estrogen 625 microgram prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592928 | Darunavir 600 mg and ritonavir 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592928 | Darunavir 600 mg and ritonavir 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592929 | Deferasirox 100 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2592929 | Deferasirox 100 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592929 | Deferasirox 100 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2592930 | Deferasirox 400 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2592930 | Deferasirox 400 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592930 | Deferasirox 400 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2592931 | Deflazacort 12 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592931 | Deflazacort 12 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592932 | Deflazacort 24 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592932 | Deflazacort 24 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592933 | Delamanid 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592933 | Delamanid 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592934 | Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592934 | Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592935 | Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592935 | Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592936 | Diacerein 50 mg and glucosamine sulfate potassium chloride 1.5 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592936 | Diacerein 50 mg and glucosamine sulfate potassium chloride 1.5 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592937 | Domperidone (as domperidone maleate) 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592937 | Domperidone (as domperidone maleate) 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592938 | Domperidone 10 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592938 | Domperidone 10 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592939 | Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592939 | Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 259294 | coal tar 1.1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259294 | coal tar 1.1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592940 | Donepezil (as donepezil hydrochloride) 5 mg and memantine (as memantine hydrochloride) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592940 | Donepezil (as donepezil hydrochloride) 5 mg and memantine (as memantine hydrochloride) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592941 | Doxofylline 400 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592941 | Doxofylline 400 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592942 | Dutasteride 500 microgram and silodosin 8 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592942 | Dutasteride 500 microgram and silodosin 8 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592943 | Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592943 | Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592944 | Etizolam 500 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592944 | Etizolam 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592945 | Etoricoxib 30 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592945 | Etoricoxib 30 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592946 | Faropenem (as faropenem sodium) 200 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592946 | Faropenem (as faropenem sodium) 200 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592947 | Favipiravir 200 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592947 | Favipiravir 200 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592948 | Favipiravir 400 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592948 | Favipiravir 400 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592949 | Fenofibrate micronised 67 mg and rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet | British preferred term (PTGB) | NO | |
| RxCUI: 2592949 | Fenofibrate micronised 67 mg and rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592949 | Fenofibrate micronised 67 mg and rosuvastatin (as rosuvastatin calcium) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592950 | Finasteride 5 mg and tamsulosin hydrochloride 400 microgram prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592950 | Finasteride 5 mg and tamsulosin hydrochloride 400 microgram prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592951 | Furazolidone 100 mg and metronidazole 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592951 | Furazolidone 100 mg and metronidazole 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592952 | nalmefene Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2592953 | nalmefene hydrochloride 2 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2592953 | nalmefene hydrochloride 2 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2592953 | nalmefene hydrochloride 2 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2592954 | nalmefene 1 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2592955 | Furosemide 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592955 | Furosemide 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592956 | Abutilon theophrasti seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592957 | Alpinia oxyphylla fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592958 | aluminum hexafluorosilicate nonahydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592959 | Chaenomeles japonica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592960 | chalcone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592961 | Cirsium arvense stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592962 | Combretum indicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592963 | Crateva magna bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592964 | Cynomorium songaricum stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592965 | Datura metel flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592966 | Gamolenic acid 120 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592966 | Gamolenic acid 120 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592967 | Descurainia sophia seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592968 | Fritillaria delavayi whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592969 | honey mushroom extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592970 | Leuzea rhapontica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592971 | Gliclazide 60 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592971 | Gliclazide 60 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592972 | Lonicera hypoglauca flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2592973 | Lygodium japonicum spore extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592974 | Magnolia denudata flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592975 | Nardostachys chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592976 | Panicum miliaceum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592977 | Pteris ensiformis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592978 | Sargassum pallidum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592979 | Solanum virginianum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592980 | Stachyurus chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592981 | Taraxacum sinicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592982 | Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592982 | Glucosamine sulfate (as glucosamine sulfate sodium chloride) 1.5 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592983 | Trichosanthes kirilowii seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592984 | Vitex negundo fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2592985 | Sodium hyaluronate 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592985 | Sodium hyaluronate 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592985 | Sodium hyaluronate 20 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2592986 | Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592986 | Indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592987 | L-ornithine L-aspartate 150 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592987 | L-ornithine L-aspartate 150 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592988 | Levamisole hydrochloride 150 mg and mebendazole 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592988 | Levamisole hydrochloride 150 mg and mebendazole 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592989 | Levosulpiride 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592989 | Levosulpiride 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592990 | Loperamide hydrochloride 2 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592990 | Loperamide hydrochloride 2 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592991 | Losartan potassium 12.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592991 | Losartan potassium 12.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592992 | Mecobalamin 1.5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592992 | Mecobalamin 1.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592994 | Metformin hydrochloride 1 g and vildagliptin 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592994 | Metformin hydrochloride 1 g and vildagliptin 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592995 | Metformin hydrochloride 500 mg and vildagliptin 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592995 | Metformin hydrochloride 500 mg and vildagliptin 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592996 | Methylphenidate hydrochloride 10 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 2592996 | Methylphenidate hydrochloride 10 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 2592997 | Metoprolol tartrate (as metoprolol succinate) 12.5 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592997 | Metoprolol tartrate (as metoprolol succinate) 12.5 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592998 | Misoprostol 600 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592998 | Misoprostol 600 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2592999 | Mosapride citrate 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2592999 | Mosapride citrate 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 25930 | Glutamine-scyllo-inosose aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 25930 | Glutamine-scyllo-inosose aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2593000 | Nitazoxanide 200 mg tablet for oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593000 | Nitazoxanide 200 mg tablet for oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593000 | Nitazoxanide 200 mg tablet for oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259305 | glycerin 1 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 259306 | alosetron HCl 1 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 259306 | alosetron HCl 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259306 | alosetron HCl 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259306 | alosetron HCl 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259306 | alosetron HCl 1 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 259309 | Cimetidine 10 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 259309 | Cimetidine 10 mg/mL oral suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259309 | Cimetidine 10 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 25931 | Glutamine-synthetase adenylyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 25931 | Glutamine-synthetase adenylyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 25931 | Glutamine-synthetase adenylyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259311 | gatifloxacin 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593118 | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (vIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2593118 | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (vIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593119 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259312 | linoleic acid 1000 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259312 | linoleic acid 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593120 | acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Quadracel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2593121 | Quadracel (with vIPV) vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2593121 | Quadracel (with vIPV) vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593121 | Quadracel (with vIPV) vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593122 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593127 | Duloxetine (as duloxetine hydrochloride) 20 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593127 | Duloxetine (as duloxetine hydrochloride) 20 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593130 | Norfloxacin 400 mg and tinidazole 600 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593130 | Norfloxacin 400 mg and tinidazole 600 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593131 | Ofloxacin 200 mg and ornidazole 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593131 | Ofloxacin 200 mg and ornidazole 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593132 | Ofloxacin 200 mg and tinidazole 600 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593132 | Ofloxacin 200 mg and tinidazole 600 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593133 | Opipramol hydrochloride 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593133 | Opipramol hydrochloride 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593134 | Ormeloxifene hydrochloride 60 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593134 | Ormeloxifene hydrochloride 60 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593135 | Oxycodone hydrochloride 10 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593135 | Oxycodone hydrochloride 10 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593136 | Oxycodone hydrochloride 20 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593136 | Oxycodone hydrochloride 20 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593137 | Oxycodone hydrochloride 5 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593137 | Oxycodone hydrochloride 5 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593138 | Pheniramine maleate 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593138 | Pheniramine maleate 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 259314 | black pepper preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2593140 | Pramipexole (as pramipexole dihydrochloride) 1.05 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593140 | Pramipexole (as pramipexole dihydrochloride) 1.05 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593141 | Pramipexole (as pramipexole dihydrochloride) 1.05 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593141 | Pramipexole (as pramipexole dihydrochloride) 1.05 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593142 | Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593142 | Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593143 | Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593143 | Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593144 | Pramipexole (as pramipexole dihydrochloride) 2.1 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593144 | Pramipexole (as pramipexole dihydrochloride) 2.1 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593145 | Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593145 | Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593146 | Pramipexole (as pramipexole dihydrochloride) 260 microgram prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593146 | Pramipexole (as pramipexole dihydrochloride) 260 microgram prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593147 | Pramipexole (as pramipexole dihydrochloride) 3.15 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593147 | Pramipexole (as pramipexole dihydrochloride) 3.15 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593148 | Pramipexole (as pramipexole dihydrochloride) 350 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593148 | Pramipexole (as pramipexole dihydrochloride) 350 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593149 | Pramipexole (as pramipexole dihydrochloride) 520 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593149 | Pramipexole (as pramipexole dihydrochloride) 520 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593150 | Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593150 | Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593151 | Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593151 | Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593152 | Pramipexole (as pramipexole dihydrochloride) 88 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593152 | Pramipexole (as pramipexole dihydrochloride) 88 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593153 | Primaquine (as primaquine phosphate) 15 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593153 | Primaquine (as primaquine phosphate) 15 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593154 | Product containing precisely ranolazine 375 milligram/1 each prolonged-release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593154 | Product containing precisely ranolazine 375 milligram/1 each prolonged-release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593155 | Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593155 | Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593156 | Product containing precisely rebamipide 100 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593156 | Product containing precisely rebamipide 100 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593157 | Product containing precisely remogliflozin etabonate 100 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593157 | Product containing precisely remogliflozin etabonate 100 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593158 | Product containing precisely rifaximin 400 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593158 | Product containing precisely rifaximin 400 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593159 | Product containing precisely rupatadine (as rupatadine fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593159 | Product containing precisely rupatadine (as rupatadine fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593160 | Product containing precisely saroglitazar 4 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593160 | Product containing precisely saroglitazar 4 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593161 | Product containing precisely secnidazole 1 gram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593161 | Product containing precisely secnidazole 1 gram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593162 | Spironolactone 50 mg and torasemide 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593162 | Spironolactone 50 mg and torasemide 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593162 | Spironolactone 50 mg and torasemide 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593163 | Spironolactone 50 mg and torasemide 20 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593163 | Spironolactone 50 mg and torasemide 20 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593163 | Spironolactone 50 mg and torasemide 20 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2593164 | Product containing precisely sulfasalazine 1 gram/1 each gastro-resistant oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593164 | Product containing precisely sulfasalazine 1 gram/1 each gastro-resistant oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593165 | Product containing precisely tacrolimus 3 milligram/1 each prolonged-release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593165 | Product containing precisely tacrolimus 3 milligram/1 each prolonged-release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593166 | Product containing precisely teneligliptin (as teneligliptin hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593166 | Product containing precisely teneligliptin (as teneligliptin hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593167 | Product containing precisely tianeptine sodium 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593167 | Product containing precisely tianeptine sodium 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593168 | Product containing precisely ticagrelor 90 milligram/1 each conventional release orodispersible tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593168 | Product containing precisely ticagrelor 90 milligram/1 each conventional release orodispersible tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593169 | Product containing precisely tolperisone hydrochloride 150 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593169 | Product containing precisely tolperisone hydrochloride 150 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593170 | Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593170 | Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593171 | Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593171 | Product containing precisely voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593172 | Product containing precisely voglibose 300 microgram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593172 | Product containing precisely voglibose 300 microgram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593176 | valerian oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593177 | 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593178 | corydine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593179 | dioctyltin bis(propylene glycol maleate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259318 | Pemirolast potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259318 | Pemirolast potassium | Designated preferred name (PT) | YES | |
| RxCUI: 259318 | Pemirolast potassium | Full form of descriptor (FN) | YES | |
| RxCUI: 2593180 | epoxiconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593181 | Eucalyptus piperita leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593183 | potassium aluminum silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593183 | potassium aluminum silicate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593184 | penconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259319 | Pioglitazone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259319 | Pioglitazone hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 259319 | Pioglitazone hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 25932 | Peptidoglutaminase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25932 | Peptidoglutaminase II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25932 | Peptidoglutaminase II | Designated preferred name (PT) | NO | |
| RxCUI: 25932 | Peptidoglutaminase II | Full form of descriptor (FN) | NO | |
| RxCUI: 259320 | plant stanol ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259321 | somatropin, E-coli derived | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259323 | coenzyme Q10 200 MG Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259323 | coenzyme Q10 200 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259324 | bismuth subgallate 2.25 % / hydrocortisone 10 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259324 | bismuth subgallate 2.25 % / hydrocortisone 10 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259328 | methyl salicylate 40 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259328 | methyl salicylate 40 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259328 | methyl salicylate 40 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 25933 | Glutaminyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25933 | Glutaminyl-tRNA synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 25933 | Glutaminyl-tRNA synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 25933 | Glutaminyl-tRNA synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259335 | Imidapril hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259335 | Imidapril hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 259335 | Imidapril hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2593371 | oxogestone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593372 | reductic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593373 | Berberis repens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593374 | baclofen 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2593375 | baclofen Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2593376 | baclofen 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593376 | baclofen 5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593376 | baclofen 5 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2593377 | Fleqsuvy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2593378 | baclofen 5 MG/ML [Fleqsuvy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2593379 | Fleqsuvy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 259338 | Cetrorelix acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 259338 | Cetrorelix acetate | Designated preferred name (PT) | YES | |
| RxCUI: 259338 | Cetrorelix acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 2593380 | Fleqsuvy Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2593381 | baclofen Oral Suspension [Fleqsuvy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2593382 | Fleqsuvy 5 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2593382 | Fleqsuvy 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593382 | Fleqsuvy 5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593382 | Fleqsuvy 5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593400 | influenza B virus B/Michigan/01/2021 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2593413 | sesamin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593414 | Salvia microphylla whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593415 | lanadelumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2593416 | lanadelumab-flyo 300 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2593416 | lanadelumab-flyo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593416 | lanadelumab-flyo 300 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593416 | lanadelumab-flyo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593417 | lanadelumab-flyo 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593418 | lanadelumab Prefilled Syringe [Takhzyro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2593419 | Takhzyro 300 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2593419 | Takhzyro 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593419 | Takhzyro 300 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593419 | Takhzyro 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259342 | cayenne extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593420 | lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593420 | lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593426 | Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2593426 | Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2593427 | Alpha/beta-arteether | Designated preferred name (PT) | NO | |
| RxCUI: 2593427 | Alpha/beta-arteether | Full form of descriptor (FN) | NO | |
| RxCUI: 2593428 | Ambroxol hydrochloride 2.5 mg/actuation oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2593428 | Ambroxol hydrochloride 2.5 mg/actuation oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2593430 | Anthraquinone laxative agent | Designated preferred name (PT) | NO | |
| RxCUI: 2593430 | Anthraquinone laxative agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2593431 | Azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/actuation nasal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2593431 | Azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/actuation nasal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2593433 | Bendamustine hydrochloride 90 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593433 | Bendamustine hydrochloride 90 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593435 | Ampicillin (as ampicillin sodium) 250 mg and cloxacillin (as cloxacillin sodium) 250 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593435 | Ampicillin (as ampicillin sodium) 250 mg and cloxacillin (as cloxacillin sodium) 250 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593436 | Arginine 3 g and proanthocyanidin 75 mg granules for oral suspension sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2593436 | Arginine 3 g and proanthocyanidin 75 mg granules for oral suspension sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2593437 | Atomoxetine (as atomoxetine hydrochloride) 4 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593437 | Atomoxetine (as atomoxetine hydrochloride) 4 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593438 | Azithromycin dihydrate 15 mg/g eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2593438 | Azithromycin dihydrate 15 mg/g eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2593439 | Barbiturate anticonvulsant agent | Designated preferred name (PT) | NO | |
| RxCUI: 2593439 | Barbiturate anticonvulsant agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2593440 | Bimatoprost 300 microgram/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2593440 | Bimatoprost 300 microgram/mL and timolol (as timolol maleate) 5 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2593441 | Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2593441 | Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2593442 | Budesonide 500 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2593442 | Budesonide 500 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2593443 | Calcium gluconate 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593443 | Calcium gluconate 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593445 | Chlorhexidine gluconate 2.5 mg/g and metronidazole 10 mg/g dental gel | Designated preferred name (PT) | NO | |
| RxCUI: 2593445 | Chlorhexidine gluconate 2.5 mg/g and metronidazole 10 mg/g dental gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2593446 | Clarithromycin citrate | Designated preferred name (PT) | NO | |
| RxCUI: 2593446 | Clarithromycin citrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593447 | Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593447 | Clavulanic acid (as clavulanate potassium) 100 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593448 | Clobazam 1 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593448 | Clobazam 1 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593449 | Clobazam 2 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593449 | Clobazam 2 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593450 | Clobetasol propionate 500 microgram/g and gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment | Designated preferred name (PT) | NO | |
| RxCUI: 2593450 | Clobetasol propionate 500 microgram/g and gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 2593451 | Coal tar 40 mg/mL and ketoconazole 20 mg/mL cutaneous lotion | Designated preferred name (PT) | NO | |
| RxCUI: 2593451 | Coal tar 40 mg/mL and ketoconazole 20 mg/mL cutaneous lotion | Full form of descriptor (FN) | NO | |
| RxCUI: 2593453 | Convalescent plasma | Designated preferred name (PT) | NO | |
| RxCUI: 2593453 | Convalescent plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 2593453 | Convalescent plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 2593455 | Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593455 | Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593455 | Tetracosactide (as tetracosactide acetate) 250 microgram/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593456 | Anti-deamidated gliadin peptide IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593456 | Anti-deamidated gliadin peptide IgA | Designated preferred name (PT) | NO | |
| RxCUI: 2593456 | Anti-deamidated gliadin peptide IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593456 | Anti-deamidated gliadin peptide IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593456 | Anti-deamidated gliadin peptide IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 2593457 | Anti-deamidated gliadin peptide IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593457 | Anti-deamidated gliadin peptide IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2593457 | Anti-deamidated gliadin peptide IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593457 | Anti-deamidated gliadin peptide IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593457 | Anti-deamidated gliadin peptide IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2593458 | Desmopressin (as desmopressin acetate) 120 microgram oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593458 | Desmopressin (as desmopressin acetate) 120 microgram oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593459 | Desmopressin (as desmopressin acetate) 240 microgram oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593459 | Desmopressin (as desmopressin acetate) 240 microgram oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 259346 | ferrous sulfate,dried | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2593460 | Desmopressin (as desmopressin acetate) 25 microgram oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593460 | Desmopressin (as desmopressin acetate) 25 microgram oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593461 | Desmopressin (as desmopressin acetate) 50 microgram oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593461 | Desmopressin (as desmopressin acetate) 50 microgram oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593462 | Desmopressin (as desmopressin acetate) 60 microgram oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593462 | Desmopressin (as desmopressin acetate) 60 microgram oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593463 | Dexamethasone (as dexamethasone sodium phosphate) 1 mg/mL and ofloxacin 3 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2593463 | Dexamethasone (as dexamethasone sodium phosphate) 1 mg/mL and ofloxacin 3 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2593464 | Dexrabeprazole sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2593464 | Dexrabeprazole sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2593465 | Digestant agent | Designated preferred name (PT) | NO | |
| RxCUI: 2593465 | Digestant agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2593466 | Diltiazem hydrochloride 20 mg/g rectal gel | Designated preferred name (PT) | NO | |
| RxCUI: 2593466 | Diltiazem hydrochloride 20 mg/g rectal gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2593467 | Drotaverine hydrochloride 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593467 | Drotaverine hydrochloride 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593468 | Eberconazole (as eberconazole nitrate) 10 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2593468 | Eberconazole (as eberconazole nitrate) 10 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2593469 | Eptacog alfa 1 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593469 | Eptacog alfa 1 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593470 | Eptacog alfa 2 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593470 | Eptacog alfa 2 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593471 | Eptacog alfa 5 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593471 | Eptacog alfa 5 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593472 | Eptacog alfa 8 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593472 | Eptacog alfa 8 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593473 | Eslicarbazepine acetate 50 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593473 | Eslicarbazepine acetate 50 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593474 | Fropenem sodium | Designated preferred name (PT) | NO | |
| RxCUI: 2593474 | Fropenem sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 2593474 | Fropenem sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593475 | FGFR (fibroblast growth factor receptor inhibitor) inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593475 | FGFR (fibroblast growth factor receptor inhibitor) inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2593475 | FGFR (fibroblast growth factor receptor inhibitor) inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2593476 | Fluconazole 3 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 2593476 | Fluconazole 3 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2593477 | Flurbiprofen 2.91 mg/actuation oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2593477 | Flurbiprofen 2.91 mg/actuation oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2593478 | Fomepizole (as fomepizole sulfate) 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593478 | Fomepizole (as fomepizole sulfate) 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593479 | Formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2593479 | Formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2593480 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593480 | Fosfomycin (as fosfomycin sodium) 2 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593481 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593481 | Fosfomycin (as fosfomycin sodium) 4 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593482 | Fosfomycin (as fosfomycin sodium) 8 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593482 | Fosfomycin (as fosfomycin sodium) 8 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593483 | Framycetin sulfate 10 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2593483 | Framycetin sulfate 10 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2593484 | Furazolidone 6 mg/mL and metronidazole (as metronidazole benzoate) 20 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593484 | Furazolidone 6 mg/mL and metronidazole (as metronidazole benzoate) 20 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593486 | Glycerol 0.05 mL/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593486 | Glycerol 0.05 mL/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593486 | Glycerol 0.05 mL/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593487 | Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593487 | Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593487 | Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593488 | Guselkumab 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593488 | Guselkumab 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593489 | HER2 (Human epidermal growth factor receptor 2) inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593489 | HER2 (Human epidermal growth factor receptor 2) inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2593489 | HER2 (Human epidermal growth factor receptor 2) inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2593490 | Hydromorphone hydrochloride 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593490 | Hydromorphone hydrochloride 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593491 | Hydromorphone hydrochloride 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593491 | Hydromorphone hydrochloride 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593492 | Ibuprofen 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593492 | Ibuprofen 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593493 | Infliximab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593493 | Infliximab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593494 | Insulin degludec 100 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593494 | Insulin degludec 100 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593495 | Interferon beta-1a (as peginterferon beta-1a) 250 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593495 | Interferon beta-1a (as peginterferon beta-1a) 250 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593496 | Iodine (as iodixanol) 270 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593496 | Iodine (as iodixanol) 270 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593497 | Iodine (as iodixanol) 320 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593497 | Iodine (as iodixanol) 320 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593498 | Iodine (as iohexol) 240 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593498 | Iodine (as iohexol) 240 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593499 | Iodine (as iohexol) 300 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593499 | Iodine (as iohexol) 300 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 259350 | miranol 2MHT modified | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593500 | Iodine (as iohexol) 350 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593500 | Iodine (as iohexol) 350 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593501 | Iodine (as iomeprol) 250 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593501 | Iodine (as iomeprol) 250 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593502 | Iodine (as iomeprol) 300 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593502 | Iodine (as iomeprol) 300 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593503 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593503 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2593503 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | British preferred term (PTGB) | NO | |
| RxCUI: 2593503 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593503 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2593504 | Iron (as ferric derisomaltose) 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593504 | Iron (as ferric derisomaltose) 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593505 | Itolizumab 100 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593505 | Itolizumab 100 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593506 | Itolizumab 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593506 | Itolizumab 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593507 | Iodine (as iomeprol) 350 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593507 | Iodine (as iomeprol) 350 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593508 | Iodine (as iomeprol) 400 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593508 | Iodine (as iomeprol) 400 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593509 | Iodine (as iopamidol) 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593509 | Iodine (as iopamidol) 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 259351 | Melibiase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259351 | Melibiase | Designated preferred name (PT) | YES | |
| RxCUI: 259351 | Melibiase | Full form of descriptor (FN) | YES | |
| RxCUI: 259351 | Melibiase | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259351 | Melibiase | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593510 | Iodine (as iopamidol) 300 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593510 | Iodine (as iopamidol) 300 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593511 | Iodine (as iopamidol) 340 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593511 | Iodine (as iopamidol) 340 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593512 | Iodine (as iopamidol) 370 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593512 | Iodine (as iopamidol) 370 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593513 | Iodine (as iopromide) 240 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593513 | Iodine (as iopromide) 240 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593514 | Iodine (as iopromide) 300 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593514 | Iodine (as iopromide) 300 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593515 | Iodine (as iopromide) 370 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593515 | Iodine (as iopromide) 370 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593541 | Folinic acid (as calcium folinate) 15 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593541 | Folinic acid (as calcium folinate) 15 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593541 | Folinic acid (as calcium folinate) 15 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593542 | Levosalbutamol sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 2593542 | Levosalbutamol sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593542 | Levosalbutamol sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593543 | Levamisole hydrochloride 15 mg/mL and mebendazole 10 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593543 | Levamisole hydrochloride 15 mg/mL and mebendazole 10 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593544 | Levocarnitine 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593544 | Levocarnitine 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593545 | Levocetirizine dihydrochloride 5 mg/mL oral drops | Designated preferred name (PT) | NO | |
| RxCUI: 2593545 | Levocetirizine dihydrochloride 5 mg/mL oral drops | Full form of descriptor (FN) | NO | |
| RxCUI: 2593546 | Lidocaine 15 mg/g and nifedipine 3 mg/g rectal cream | Designated preferred name (PT) | NO | |
| RxCUI: 2593546 | Lidocaine 15 mg/g and nifedipine 3 mg/g rectal cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2593547 | Lidocaine 150 mg/g cutaneous spray | Designated preferred name (PT) | NO | |
| RxCUI: 2593547 | Lidocaine 150 mg/g cutaneous spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2593548 | Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream | Designated preferred name (PT) | NO | |
| RxCUI: 2593548 | Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream | Full form of descriptor (FN) | NO | |
| RxCUI: 2593550 | Light liquid paraffin 634 mg/g cutaneous oil for bathing | Designated preferred name (PT) | NO | |
| RxCUI: 2593550 | Light liquid paraffin 634 mg/g cutaneous oil for bathing | Full form of descriptor (FN) | NO | |
| RxCUI: 2593551 | Lorazepam 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593551 | Lorazepam 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593552 | Lysine hydrochloride 150 mg/g cutaneous ointment | Designated preferred name (PT) | NO | |
| RxCUI: 2593552 | Lysine hydrochloride 150 mg/g cutaneous ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 2593553 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion | Designated preferred name (PT) | NO | |
| RxCUI: 2593553 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion | British preferred term (PTGB) | NO | |
| RxCUI: 2593553 | Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion | Full form of descriptor (FN) | NO | |
| RxCUI: 2593554 | Magnesium sulfate heptahydrate 500 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593554 | Magnesium sulfate heptahydrate 500 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593555 | Memantine hydrochloride 10 mg/mL oral solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593555 | Memantine hydrochloride 10 mg/mL oral solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593556 | Medicinal product containing mercury compound and acting as diuretic agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593556 | Medicinal product containing mercury compound and acting as diuretic agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2593559 | MET (mesenchymal epithelial transition) inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2593559 | MET (mesenchymal epithelial transition) inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593559 | MET (mesenchymal epithelial transition) inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2593560 | Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593560 | Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593561 | Methylthioninium chloride 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593561 | Methylthioninium chloride 5 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593561 | Methylthioninium chloride 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593562 | Midazolam (as midazolam hydrochloride) 5 mg/mL oromucosal solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593562 | Midazolam (as midazolam hydrochloride) 5 mg/mL oromucosal solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593563 | Minoxidil 100 mg/mL cutaneous solution | Designated preferred name (PT) | NO | |
| RxCUI: 2593563 | Minoxidil 100 mg/mL cutaneous solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2593564 | Medicinal product containing monobactam and acting as antibacterial agent (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593564 | Medicinal product containing monobactam and acting as antibacterial agent (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2593565 | Morphine sulfate 60 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593565 | Morphine sulfate 60 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593567 | Neostigmine methylsulfate 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593567 | Neostigmine methylsulfate 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593568 | Nicotine 1 mg/actuation oromucosal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2593568 | Nicotine 1 mg/actuation oromucosal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2593569 | Nivolumab 10 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2593569 | Nivolumab 10 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 259357 | boron gluconate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593570 | Nonacog alfa 1000 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593570 | Nonacog alfa 1000 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593571 | Nonacog alfa 250 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593571 | Nonacog alfa 250 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593572 | Nonacog alfa 500 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593572 | Nonacog alfa 500 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593573 | Octocog alfa 250 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593573 | Octocog alfa 250 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593574 | Octocog alfa 500 unit powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593574 | Octocog alfa 500 unit powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593575 | Ofloxacin 10 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593575 | Ofloxacin 10 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593576 | Oliceridine (as oliceridine fumarate) 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593576 | Oliceridine (as oliceridine fumarate) 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593577 | Omalizumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593577 | Omalizumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593578 | Omeprazole 4 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2593578 | Omeprazole 4 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2593579 | Ondansetron 4 mg oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593579 | Ondansetron 4 mg oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 259358 | Berberine chloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259358 | Berberine chloride | Designated preferred name (PT) | NO | |
| RxCUI: 259358 | Berberine chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2593580 | Ondansetron 8 mg oral lyophilisate | Designated preferred name (PT) | NO | |
| RxCUI: 2593580 | Ondansetron 8 mg oral lyophilisate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593581 | Centchroman hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593581 | Centchroman hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2593581 | Centchroman hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2593582 | Medicinal product acting as osmotic diuretic (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593582 | Medicinal product acting as osmotic diuretic (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2593583 | Oxycodone hydrochloride 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593583 | Oxycodone hydrochloride 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593584 | Adenosine diphosphate receptor subtype P2Y12 antagonist | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593584 | Adenosine diphosphate receptor subtype P2Y12 antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2593584 | Adenosine diphosphate receptor subtype P2Y12 antagonist | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593584 | Adenosine diphosphate receptor subtype P2Y12 antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2593585 | Paliperidone (as paliperidone palmitate) 200 mg/mL prolonged-release suspension for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593585 | Paliperidone (as paliperidone palmitate) 200 mg/mL prolonged-release suspension for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593587 | Platelet glycoprotein-IIb/IIIa receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2593587 | Platelet glycoprotein-IIb/IIIa receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2593588 | Product containing precisely rabeprazole sodium 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593588 | Product containing precisely rabeprazole sodium 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593589 | Product containing precisely racecadotril 10 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593589 | Product containing precisely racecadotril 10 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593590 | Product containing precisely racecadotril 15 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593590 | Product containing precisely racecadotril 15 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593591 | Product containing precisely racecadotril 30 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593591 | Product containing precisely racecadotril 30 milligram/1 sachet powder for conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 259361 | dexetimide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2593650 | Rutoside trihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2593650 | Rutoside trihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593650 | Rutoside trihydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593652 | Product containing precisely samarium (153-Sm) lexidronam pentasodium 1.3 gigabecquerel/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593652 | Product containing precisely samarium (153-Sm) lexidronam pentasodium 1.3 gigabecquerel/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593653 | Product containing precisely sarilumab 131.579 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593653 | Product containing precisely sarilumab 131.579 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593654 | Product containing precisely sarilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593654 | Product containing precisely sarilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593655 | Deoxyribonucleic acid plasmid encoding 2019-nCoV encoding spike protein | Designated preferred name (PT) | NO | |
| RxCUI: 2593656 | COVID-19 DNA plasmid encoding spike protein vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593656 | COVID-19 DNA plasmid encoding spike protein vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593656 | COVID-19 DNA plasmid encoding spike protein vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2593656 | COVID-19 DNA plasmid encoding spike protein vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593656 | COVID-19 DNA plasmid encoding spike protein vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2593658 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593658 | Product containing precisely sodium bicarbonate 84 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593659 | Product containing precisely sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593659 | Product containing precisely sodium chloride 4.5 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 259366 | eyebright preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593660 | Product containing precisely ustekinumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593660 | Product containing precisely ustekinumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593661 | Product containing precisely valsartan 3 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593661 | Product containing precisely valsartan 3 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593662 | COVID-19 virus-like particle antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593662 | COVID-19 virus-like particle antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593662 | COVID-19 virus-like particle antigen vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2593662 | COVID-19 virus-like particle antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593662 | COVID-19 virus-like particle antigen vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Full form of descriptor (FN) | NO | |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593663 | Antigen of severe acute respiratory syndrome coronavirus 2 virus-like particle | Designated preferred name (PT) | NO | |
| RxCUI: 2593664 | Antigen of Streptococcus pneumoniae capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593664 | Antigen of Streptococcus pneumoniae capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593664 | Antigen of Streptococcus pneumoniae capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593664 | Antigen of Streptococcus pneumoniae capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593665 | Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593665 | Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593665 | Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593665 | Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593665 | Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593666 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593666 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593666 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593666 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593666 | Antigen of Streptococcus pneumoniae Danish serotype 12F capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593667 | Antigen of Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593667 | Antigen of Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593667 | Antigen of Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593667 | Antigen of Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593667 | Antigen of Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593668 | Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593668 | Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593668 | Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593668 | Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593668 | Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593669 | Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593669 | Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593669 | Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593669 | Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593669 | Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 259367 | Veronicastrum virginicum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593670 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593670 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide | Full form of descriptor (FN) | NO | |
| RxCUI: 2593670 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593670 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593670 | Antigen of Streptococcus pneumoniae Danish serotype 22F capsular polysaccharide | Designated preferred name (PT) | NO | |
| RxCUI: 2593671 | Antigen of Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593671 | Antigen of Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593671 | Antigen of Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593671 | Antigen of Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593671 | Antigen of Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593672 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593672 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593672 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593672 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593672 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593673 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593673 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593673 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593673 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593673 | Antigen of Streptococcus pneumoniae Danish serotype 3 capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593674 | Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593674 | Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593674 | Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593674 | Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593674 | Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593675 | Antigen of Streptococcus pneumoniae Danish serotype 6A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593675 | Antigen of Streptococcus pneumoniae Danish serotype 6A capsular polysaccharide conjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593675 | Antigen of Streptococcus pneumoniae Danish serotype 6A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593675 | Antigen of Streptococcus pneumoniae Danish serotype 6A capsular polysaccharide conjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593675 | Antigen of Streptococcus pneumoniae Danish serotype 6A capsular polysaccharide conjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593676 | Antigen of Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593676 | Antigen of Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593676 | Antigen of Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593676 | Antigen of Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593676 | Antigen of Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593677 | Antigen of Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593677 | Antigen of Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593677 | Antigen of Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593677 | Antigen of Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593677 | Antigen of Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593678 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593678 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593678 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593678 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593678 | Antigen of Streptococcus pneumoniae Danish serotype 8 capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593679 | Antigen of Streptococcus pneumoniae Danish serotype 9N capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593679 | Antigen of Streptococcus pneumoniae Danish serotype 9N capsular polysaccharide unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 2593679 | Antigen of Streptococcus pneumoniae Danish serotype 9N capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593679 | Antigen of Streptococcus pneumoniae Danish serotype 9N capsular polysaccharide unconjugated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593679 | Antigen of Streptococcus pneumoniae Danish serotype 9N capsular polysaccharide unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593680 | Hepatitis B surface antigen immunoglobulin 500 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593680 | Hepatitis B surface antigen immunoglobulin 500 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593681 | Human anti-D immunoglobulin 750 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593681 | Human anti-D immunoglobulin 750 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593682 | Staphylococcus aureus TSST-1 (toxic shock syndrome toxin 1) specific immunoglobulin E | Designated preferred name (PT) | NO | |
| RxCUI: 2593682 | Staphylococcus aureus TSST-1 (toxic shock syndrome toxin 1) specific immunoglobulin E | Full form of descriptor (FN) | NO | |
| RxCUI: 2593682 | Staphylococcus aureus TSST-1 (toxic shock syndrome toxin 1) specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593682 | Staphylococcus aureus TSST-1 (toxic shock syndrome toxin 1) specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593683 | Artemisinin and/or artemisinin derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2593683 | Artemisinin and/or artemisinin derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2593684 | Artemisinin derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2593684 | Artemisinin derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2593685 | Botulinum toxin type A and/or botulinum toxin type A derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2593685 | Botulinum toxin type A and/or botulinum toxin type A derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2593686 | Allylestrenol micronised | British preferred term (PTGB) | NO | |
| RxCUI: 2593686 | Allylestrenol micronised | Designated preferred name (PT) | NO | |
| RxCUI: 2593686 | Allylestrenol micronised | Full form of descriptor (FN) | NO | |
| RxCUI: 2593687 | Tinospora sinensis stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593688 | Siraitia grosvenorii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593689 | Malus domestica pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593690 | Cordyceps militaris fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593691 | pomiferin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593692 | Streptococcus thermophilus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2593693 | Taiwanofungus camphoratus mycelium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593696 | Product containing precisely sugammadex (as sugammadex sodium) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593696 | Product containing precisely sugammadex (as sugammadex sodium) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593697 | Synthetic cathinone derivative | Designated preferred name (PT) | NO | |
| RxCUI: 2593697 | Synthetic cathinone derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 2593698 | Product containing precisely tapentadol (as tapentadol hydrochloride) 4 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593698 | Product containing precisely tapentadol (as tapentadol hydrochloride) 4 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593699 | Teneligliptin hydrobromide | Designated preferred name (PT) | NO | |
| RxCUI: 2593699 | Teneligliptin hydrobromide | Full form of descriptor (FN) | NO | |
| RxCUI: 2593700 | Product containing precisely terlipressin acetate 100 microgram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593700 | Product containing precisely terlipressin acetate 100 microgram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593701 | Product containing precisely terlipressin acetate 120 microgram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593701 | Product containing precisely terlipressin acetate 120 microgram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593702 | Testosterone enantate 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593702 | Testosterone enantate 200 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593702 | Testosterone enantate 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593703 | Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter and travoprost 40 microgram/1 milliliter conventional release eye drops (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593703 | Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter and travoprost 40 microgram/1 milliliter conventional release eye drops (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593705 | Tivozanib hydrochloride monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2593705 | Tivozanib hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2593706 | Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593706 | Product containing precisely tocilizumab 180 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593707 | Product containing precisely trastuzumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593707 | Product containing precisely trastuzumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593708 | Product containing precisely urokinase 500000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593708 | Product containing precisely urokinase 500000 unit/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593709 | Product containing precisely valethamate bromide 8 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593709 | Product containing precisely valethamate bromide 8 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593710 | Product containing precisely zanamivir 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593710 | Product containing precisely zanamivir 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593711 | apple cider | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593712 | Product containing precisely somatropin 5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593712 | Product containing precisely somatropin 5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593713 | Product containing precisely somatropin 5.825 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593713 | Product containing precisely somatropin 5.825 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593714 | Product containing precisely somatropin 8 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2593714 | Product containing precisely somatropin 8 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2593715 | glycerin 0.9 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593715 | glycerin 0.9 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593715 | glycerin 0.9 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593716 | amyloglucosidase (Aspergillus niger) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593717 | aspergillopepsin I (Aspergillus phoenicis) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593719 | Estrone, unconjugated | Designated preferred name (PT) | NO | |
| RxCUI: 2593719 | Estrone, unconjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 259372 | fructooligosaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259372 | fructooligosaccharide | Designated preferred name (PT) | YES | |
| RxCUI: 259372 | fructooligosaccharide | Full form of descriptor (FN) | YES | |
| RxCUI: 259379 | dihydralazine sul hemipenthy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259380 | Vervain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259380 | Vervain | Designated preferred name (PT) | NO | |
| RxCUI: 259380 | Vervain | Full form of descriptor (FN) | NO | |
| RxCUI: 2593841 | Human immunoglobulin G 6 G powder for solution for injection vial | Designated preferred name (PT) | NO | |
| RxCUI: 2593841 | Human immunoglobulin G 6 G powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| RxCUI: 2593842 | Normal human immunoglobulin 165 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2593842 | Normal human immunoglobulin 165 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2593843 | Comirnaty | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2593844 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML [Comirnaty] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2593845 | Comirnaty Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2593846 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Comirnaty] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2593847 | COMIRNATY 30 MCG/0.3 ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593847 | COMIRNATY 30 MCG/0.3 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593847 | COMIRNATY 30 MCG/0.3 ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2593848 | Justicia spicigera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259385 | ginseng root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593852 | behenyl acrylate polymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593853 | 5-methyl-1,3,5-triphenyl-2-pyrazoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2593854 | influenza A virus A/Darwin/9/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2593855 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2593856 | influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2593857 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2593857 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593857 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593858 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593858 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593858 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593859 | Fluzone Quadrivalent 2022 Southern Hemisphere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2593860 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022 Southern Hemisphere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2593861 | Fluzone Quadrivalent 2022 Southern Hemisphere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2593862 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2593863 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593863 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593863 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593864 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593865 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2593865 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2593865 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2593866 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022 Southern Hemisphere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2593867 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593867 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593867 | Fluzone Quadrivalent 2022 Southern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593902 | Smilax officinalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593903 | chloroquine diphosphate, (R)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2593941 | Eschscholzia californica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593942 | Gossypium herbaceum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2593943 | tripelennamine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2593944 | tripelennamine Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2593945 | tripelennamine hydrochloride 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593945 | tripelennamine hydrochloride 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2593946 | Re-Covr | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2593947 | tripelennamine hydrochloride 20 MG/ML [Re-Covr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2593948 | Re-Covr Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2593949 | tripelennamine Injectable Solution [Re-Covr] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2593950 | RE-COVR 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593950 | RE-COVR 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2593950 | RE-COVR 20 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2593955 | salicylic acid 1 % Medicated Liquid Soap (30 ML) / salicylic acid 1 % Topical Cream (30 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2593955 | salicylic acid 1 % Medicated Liquid Soap (30 ML) / salicylic acid 1 % Topical Cream (30 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2593955 | salicylic acid 1 % Medicated Liquid Soap (30 ML) / salicylic acid 1 % Topical Cream (30 ML) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259399 | amilomer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594 | Clofibrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594 | Clofibrate | Designated preferred name (PT) | NO | |
| RxCUI: 2594 | Clofibrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2594 | Clofibrate | Designated preferred name (PT) | NO | |
| RxCUI: 2594 | Clofibrate | Full form of descriptor (FN) | NO | |
| RxCUI: 259404 | barberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594042 | Normal human immunoglobulin 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| RxCUI: 2594042 | Normal human immunoglobulin 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| RxCUI: 2594043 | Normal human immunoglobulin 50 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2594043 | Normal human immunoglobulin 50 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2594048 | epinephrine 0.125 MG/ACTUAT [Primatene Mist Inhaler] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594048 | epinephrine 0.125 MG/ACTUAT [Primatene Mist Inhaler] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 259409 | progesterone, micronized | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259412 | Griffonia preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259415 | blacksamson echinacea root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259415 | blacksamson echinacea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 25942 | Glutarate-semialdehyde dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 25942 | Glutarate-semialdehyde dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 259421 | kava root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259430 | soy germ | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259434 | slippery elm bark | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259436 | Taraxacum officinale root extract | Designated preferred name (PT) | YES | |
| RxCUI: 259436 | Taraxacum officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259436 | Taraxacum officinale root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259436 | Taraxacum officinale root extract | Full form of descriptor (FN) | YES | |
| RxCUI: 259436 | Taraxacum officinale root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594468 | mitapivat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2594469 | mitapivat 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594470 | mitapivat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2594471 | mitapivat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2594472 | mitapivat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2594473 | mitapivat 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594473 | mitapivat 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594473 | mitapivat 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594474 | Pyrukynd | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2594475 | mitapivat 20 MG [Pyrukynd] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594476 | Pyrukynd Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2594477 | Pyrukynd Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2594478 | mitapivat Oral Tablet [Pyrukynd] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2594479 | pyrukynd 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594479 | pyrukynd 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594479 | pyrukynd 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594479 | pyrukynd 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259449 | citrus paradisi seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259449 | citrus paradisi seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2594490 | camphor 26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2594491 | camphor 2.6 % / menthol 0.1 % / phenol 1.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594491 | camphor 2.6 % / menthol 0.1 % / phenol 1.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594491 | camphor 2.6 % / menthol 0.1 % / phenol 1.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594492 | allantoin 0.5 % / lidocaine HCl 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594492 | allantoin 0.5 % / lidocaine HCl 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594492 | allantoin 0.5 % / lidocaine HCl 4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594493 | salicylic acid 19.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2594494 | salicylic acid 1.95 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594494 | salicylic acid 1.95 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594494 | salicylic acid 1.95 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594495 | mitapivat 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594496 | mitapivat 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594496 | mitapivat 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594496 | mitapivat 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594497 | mitapivat 5 MG [Pyrukynd] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594498 | pyrukynd 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594498 | pyrukynd 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594498 | pyrukynd 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594498 | pyrukynd 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594500 | mitapivat 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594501 | mitapivat 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594501 | mitapivat 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594501 | mitapivat 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594502 | mitapivat 50 MG [Pyrukynd] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594503 | pyrukynd 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594503 | pyrukynd 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594503 | pyrukynd 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594503 | pyrukynd 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259453 | Levobupivacaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259453 | Levobupivacaine | Designated preferred name (PT) | NO | |
| RxCUI: 259453 | Levobupivacaine | Full form of descriptor (FN) | NO | |
| RxCUI: 259453 | Levobupivacaine | Designated preferred name (PT) | NO | |
| RxCUI: 259453 | Levobupivacaine | Full form of descriptor (FN) | NO | |
| RxCUI: 259454 | Levobupivacaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259454 | Levobupivacaine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 259454 | Levobupivacaine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2594592 | wheat germ oil unsaponifiables | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594593 | tetraethyl silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594594 | dimethicone-phenyl vinyl dimethicone crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594595 | Impatiens balsamina flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594596 | Mucuna birdwoodiana stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594597 | anisole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2594598 | lauryl lactyl lactate, DL- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594599 | lorazepam 1.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594599 | lorazepam 1.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 25946 | Glutaryl coenzyme A oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 25946 | Glutaryl coenzyme A oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 259460 | borage extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594600 | LORazepam 1.5 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594600 | LORazepam 1.5 MG 24HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2594600 | LORazepam 1.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594601 | LORazepam 1.5 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594601 | LORazepam 1.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594601 | LORazepam 1.5 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594602 | lorazepam 1.5 MG [Loreev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594602 | lorazepam 1.5 MG [Loreev] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2594603 | Loreev XR 1.5 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594603 | Loreev XR 1.5 MG 24HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2594603 | Loreev XR 1.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594603 | Loreev XR 1.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594603 | Loreev XR 1.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594604 | Loreev 1.5 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594604 | Loreev 1.5 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594604 | Loreev 1.5 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594604 | Loreev 1.5 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594605 | siponimod 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594606 | siponimod 1 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2594606 | siponimod 1 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2594606 | siponimod 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594606 | siponimod 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594607 | siponimod 1 MG [Mayzent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594608 | MAYZENT 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594608 | MAYZENT 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594608 | MAYZENT 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 259462 | lutein esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259470 | Korean ginseng preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259471 | Panax ginseng root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259471 | Panax ginseng root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259472 | Siberian ginseng root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259473 | American ginseng root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2594741 | mitapivat 20 MG 4-Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594741 | mitapivat 20 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594741 | mitapivat 20 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594742 | Pyrukynd 20 MG 4-Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594742 | Pyrukynd 20 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594742 | Pyrukynd 20 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594743 | mitapivat 5 MG 4-Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594743 | mitapivat 5 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594743 | mitapivat 5 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594744 | Pyrukynd 5 MG 4-Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594744 | Pyrukynd 5 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594744 | Pyrukynd 5 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594745 | mitapivat 5 MG Taper Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594745 | mitapivat 5 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594745 | mitapivat 5 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594746 | Pyrukynd 5 MG Taper Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594746 | Pyrukynd 5 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594746 | Pyrukynd 5 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594747 | mitapivat 5 MG / 20 MG Taper Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594747 | mitapivat 5 MG / 20 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594747 | mitapivat 5 MG / 20 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594748 | Pyrukynd 5 MG / 20 MG Taper Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594748 | Pyrukynd 5 MG / 20 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594748 | Pyrukynd 5 MG / 20 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594749 | mitapivat 50 MG / 20 MG Taper Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594749 | mitapivat 50 MG / 20 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594749 | mitapivat 50 MG / 20 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594750 | Pyrukynd 20 MG / 50 MG Taper Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594750 | Pyrukynd 20 MG / 50 MG Taper Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594750 | Pyrukynd 20 MG / 50 MG Taper Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594751 | ranolazine Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2594752 | ranolazine Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2594753 | ranolazine 1000 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594753 | ranolazine 1000 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594753 | ranolazine 1000 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594754 | Aspruzyo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2594756 | Aspruzyo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2594757 | Aspruzyo Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2594759 | ASPRUZYO Sprinkle 1000 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594759 | ASPRUZYO Sprinkle 1000 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594759 | ASPRUZYO Sprinkle 1000 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594759 | ASPRUZYO Sprinkle 1000 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594759 | ASPRUZYO Sprinkle 1000 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594760 | ranolazine 500 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594760 | ranolazine 500 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594762 | ASPRUZYO Sprinkle 500 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594762 | ASPRUZYO Sprinkle 500 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594762 | ASPRUZYO Sprinkle 500 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594762 | ASPRUZYO Sprinkle 500 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594763 | Gravol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2594764 | dimenhydrinate 3 MG/ML [Gravol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2594764 | dimenhydrinate 3 MG/ML [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594765 | Gravol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2594766 | Gravol Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2594767 | dimenhydrinate Oral Solution [Gravol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2594767 | dimenhydrinate Oral Solution [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594768 | Gravol 15 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594768 | Gravol 15 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594768 | Gravol 15 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594768 | Gravol 15 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594768 | Gravol 15 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594769 | dimenhydrinate 50 MG [Gravol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2594769 | dimenhydrinate 50 MG [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594770 | Gravol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2594771 | dimenhydrinate Oral Capsule [Gravol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2594771 | dimenhydrinate Oral Capsule [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594772 | Gravol 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594772 | Gravol 50 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594772 | Gravol 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594772 | Gravol 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594773 | dimenhydrinate Oral Tablet [Gravol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2594773 | dimenhydrinate Oral Tablet [Gravol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594774 | Gravol 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594774 | Gravol 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2594774 | Gravol 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2594774 | Gravol 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594775 | ciltacabtagene autoleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2594777 | ciltacabtagene autoleucel 1430000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594778 | ciltacabtagene autoleucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2594779 | ciltacabtagene autoleucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2594780 | ciltacabtagene autoleucel 100,000,000 CELLS in 70 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594780 | ciltacabtagene autoleucel 100,000,000 CELLS in 70 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594780 | ciltacabtagene autoleucel 100,000,000 CELLS in 70 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594781 | ciltacabtagene autoleucel 1430000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594782 | Carvykti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2594783 | ciltacabtagene autoleucel 1430000 CELLS/ML [Carvykti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594784 | Carvykti Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2594785 | ciltacabtagene autoleucel Injection [Carvykti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2594786 | CARVYKTI 100,000,000 CELLS in 70 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594786 | CARVYKTI 100,000,000 CELLS in 70 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594786 | CARVYKTI 100,000,000 CELLS in 70 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594786 | CARVYKTI 100,000,000 CELLS in 70 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594787 | ciltacabtagene autoleucel 1430000 CELLS/ML Injection [Carvykti] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594787 | ciltacabtagene autoleucel 1430000 CELLS/ML Injection [Carvykti] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594788 | ciltacabtagene autoleucel 3330000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2594789 | ciltacabtagene autoleucel 100,000,000 CELLS in 30 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594789 | ciltacabtagene autoleucel 100,000,000 CELLS in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594789 | ciltacabtagene autoleucel 100,000,000 CELLS in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594790 | ciltacabtagene autoleucel 3330000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594791 | ciltacabtagene autoleucel 3330000 CELLS/ML [Carvykti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2594792 | CARVYKTI 100,000,000 CELLS in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594792 | CARVYKTI 100,000,000 CELLS in 30 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2594792 | CARVYKTI 100,000,000 CELLS in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594792 | CARVYKTI 100,000,000 CELLS in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594793 | ciltacabtagene autoleucel 3330000 CELLS/ML Injection [Carvykti] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2594793 | ciltacabtagene autoleucel 3330000 CELLS/ML Injection [Carvykti] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2594794 | mitapivat 50 MG 4-Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594794 | mitapivat 50 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594794 | mitapivat 50 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594795 | Pyrukynd 50 MG 4-Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594795 | Pyrukynd 50 MG 4-Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594795 | Pyrukynd 50 MG 4-Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594796 | siponimod 0.25 MG (7) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2594796 | siponimod 0.25 MG (7) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594796 | siponimod 0.25 MG (7) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594797 | Mayzent 1 MG Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2594797 | Mayzent 1 MG Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594797 | Mayzent 1 MG Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25948 | Glutaryl coenzyme A dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25948 | Glutaryl coenzyme A dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 25948 | Glutaryl coenzyme A dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25948 | Glutaryl coenzyme A dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 259480 | flupirtine gluconate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259486 | loxoprofen sodium dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259487 | Manidipine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259487 | Manidipine hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 259487 | Manidipine hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 259493 | Zofenopril calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259493 | Zofenopril calcium | Designated preferred name (PT) | NO | |
| RxCUI: 259493 | Zofenopril calcium | Full form of descriptor (FN) | NO | |
| RxCUI: 2594978 | cabotegravir 400 MG in 2 ML Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594978 | cabotegravir 400 MG in 2 ML Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594978 | cabotegravir 400 MG in 2 ML Extended Release Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594979 | rilpivirine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2594980 | rilpivirine 900 MG in 3 ML Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594980 | rilpivirine 900 MG in 3 ML Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594980 | rilpivirine 900 MG in 3 ML Extended Release Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2594981 | rilpivirine 300 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2594982 | rilpivirine 600 MG in 2 ML Extended Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2594982 | rilpivirine 600 MG in 2 ML Extended Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2594982 | rilpivirine 600 MG in 2 ML Extended Release Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595041 | leuprolide mesylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2595042 | lidocaine HCl 4 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595042 | lidocaine HCl 4 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595042 | lidocaine HCl 4 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595043 | leuprolide 42 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2595044 | leuprolide 42 MG Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595044 | leuprolide 42 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595044 | leuprolide 42 MG Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595045 | Camcevi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2595046 | leuprolide 42 MG [Camcevi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2595047 | Camcevi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2595048 | leuprolide Prefilled Syringe [Camcevi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2595049 | CAMCEVI 42 MG Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595049 | CAMCEVI 42 MG Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595049 | CAMCEVI 42 MG Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 259511 | black cohosh root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 259513 | Rudbeckia purpurea root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259513 | Rudbeckia purpurea root extract | Designated preferred name (PT) | YES | |
| RxCUI: 259513 | Rudbeckia purpurea root extract | Full form of descriptor (FN) | YES | |
| RxCUI: 259513 | Rudbeckia purpurea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259513 | Rudbeckia purpurea root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25952 | Glutathione dehydrogenase (ascorbate) | Designated preferred name (PT) | NO | |
| RxCUI: 25952 | Glutathione dehydrogenase (ascorbate) | Full form of descriptor (FN) | NO | |
| RxCUI: 2595223 | Midamox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2595224 | imidacloprid 100 MG/ML / moxidectin 25 MG/ML [Midamox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2595225 | Midamox Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2595226 | imidacloprid / moxidectin Topical Solution [Midamox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2595227 | Midamox for Dogs 10 % / 2.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2595227 | Midamox for Dogs 10 % / 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595227 | Midamox for Dogs 10 % / 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2595233 | phenol 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2595234 | phenol 0.7 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2595234 | phenol 0.7 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595234 | phenol 0.7 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2595235 | simethicone 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2595235 | simethicone 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2595236 | milk protein concentrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2595242 | pacritinib citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2595243 | pacritinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2595244 | pacritinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2595245 | pacritinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2595246 | pacritinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2595247 | pacritinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2595248 | pacritinib 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595248 | pacritinib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595248 | pacritinib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595249 | Vonjo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 259525 | Apis mellifera ven protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2595250 | pacritinib 100 MG [Vonjo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2595251 | Vonjo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2595252 | Vonjo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2595253 | pacritinib Oral Capsule [Vonjo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2595254 | VONJO 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2595254 | VONJO 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595254 | VONJO 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25953 | oxiglutatione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25953 | oxiglutatione | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259531 | Atosiban acetate | Designated preferred name (PT) | NO | |
| RxCUI: 259531 | Atosiban acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 259532 | glucose 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259533 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259533 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259533 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259535 | chloroxylenol 1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259535 | chloroxylenol 1 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259535 | chloroxylenol 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259539 | Plantago seed 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259543 | clarithromycin 500 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259546 | menthol 4.26 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259546 | menthol 4.26 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259546 | menthol 4.26 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595463 | zinc oxide 149 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2595464 | zinc oxide 14.9 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2595464 | zinc oxide 14.9 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595464 | zinc oxide 14.9 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2595464 | zinc oxide 14.9 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595466 | Merzee 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2595466 | Merzee 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595466 | Merzee 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259548 | zinc pyrithione 0.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259548 | zinc pyrithione 0.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259548 | zinc pyrithione 0.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259549 | zinc pyrithione 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259549 | zinc pyrithione 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259549 | zinc pyrithione 0.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259550 | menthol 6 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259550 | menthol 6 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259550 | menthol 6 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595574 | mitapivat sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 259567 | calcium 80 MG / folic acid 1 MG / magnesium 115 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259567 | calcium 80 MG / folic acid 1 MG / magnesium 115 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259567 | calcium 80 MG / folic acid 1 MG / magnesium 115 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 25957 | Glutathione oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 25957 | Glutathione oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 259579 | menthol 1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259579 | menthol 1 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259579 | menthol 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259580 | inositol 110 MG / phytic acid 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259581 | glycerin 0.2 % / hypromellose 0.2 % / polyethylene glycol 400 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259581 | glycerin 0.2 % / hypromellose 0.2 % / polyethylene glycol 400 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259581 | glycerin 0.2 % / hypromellose 0.2 % / polyethylene glycol 400 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595841 | magnesium citrate 85 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2595842 | magnesium citrate 85 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595842 | magnesium citrate 85 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259586 | iron (as ferrous sulfate) 27 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259586 | iron (as ferrous sulfate) 27 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259586 | iron (as ferrous sulfate) 27 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259586 | iron (as ferrous sulfate) 27 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259590 | calcium 500 MG / boron 1.5 MG Oral Tablet, as calcium carbonate and boron gluconate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259590 | calcium 500 MG / boron 1.5 MG Oral Tablet, as calcium carbonate and boron gluconate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259592 | chromium picolinate 400 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259592 | chromium picolinate 400 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2595941 | .beta.-glucogallin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2595942 | filgrastim-ayow | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2595943 | filgrastim-ayow 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2595944 | filgrastim-ayow 300 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595944 | filgrastim-ayow 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595944 | filgrastim-ayow 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595944 | filgrastim-ayow 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595945 | filgrastim-ayow 0.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2595946 | Releuko | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2595947 | filgrastim-ayow 0.6 MG/ML [Releuko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2595948 | Releuko Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2595949 | filgrastim Prefilled Syringe [Releuko] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2595950 | Releuko 300 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2595950 | Releuko 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595950 | Releuko 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595950 | Releuko 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595951 | filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2595951 | filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595952 | filgrastim-ayow 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2595953 | filgrastim-ayow 300 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595953 | filgrastim-ayow 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595953 | filgrastim-ayow 300 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595953 | filgrastim-ayow 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595954 | filgrastim-ayow 0.3 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2595955 | filgrastim-ayow 0.3 MG/ML [Releuko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2595956 | filgrastim Injection [Releuko] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2595957 | Releuko 300 MCG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2595957 | Releuko 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595957 | Releuko 300 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595957 | Releuko 300 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595958 | filgrastim-ayow 0.3 MG/ML Injection [Releuko] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2595958 | filgrastim-ayow 0.3 MG/ML Injection [Releuko] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2595959 | filgrastim-ayow 480 MCG per 1.6 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595959 | filgrastim-ayow 480 MCG per 1.6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595959 | filgrastim-ayow 480 MCG per 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595960 | Releuko 480 MCG in 1.6 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2595960 | Releuko 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595960 | Releuko 480 MCG in 1.6 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595960 | Releuko 480 MCG in 1.6 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595961 | filgrastim-ayow 480 MCG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2595961 | filgrastim-ayow 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595961 | filgrastim-ayow 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595961 | filgrastim-ayow 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595962 | Releuko 480 MCG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2595962 | Releuko 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2595962 | Releuko 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2595962 | Releuko 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596 | Clomifene-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596 | Clomifene-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 2596 | Clomifene-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596 | Clomifene-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2596 | Clomifene-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 2596 | Clomifene-containing product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2596 | Clomifene-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 2596 | Clomifene-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 259611 | calfactant 35 MG/ML Intratracheal Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259611 | calfactant 35 MG/ML Intratracheal Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259613 | bromelains 375 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259614 | folate 0.8 MG / vitamin B12 2.5 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259614 | folate 0.8 MG / vitamin B12 2.5 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259614 | folate 0.8 MG / vitamin B12 2.5 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596166 | Bifidobacterium animalis 11100000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596167 | Bifidobacterium animalis Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2596168 | Bifidobacterium animalis Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2596169 | Bifidobacterium lactis 3,000,000,000 UNT in 0.27 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596169 | Bifidobacterium lactis 3,000,000,000 UNT in 0.27 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596169 | Bifidobacterium lactis 3,000,000,000 UNT in 0.27 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596172 | ceramide 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2596173 | tetrasodium edetate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2596174 | naloxone hydrochloride 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596175 | naloxone HCl 10 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596175 | naloxone HCl 10 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596175 | naloxone HCl 10 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596176 | naloxone hydrochloride 25 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596179 | Emetrol Chewables | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2596180 | sodium citrate 230 MG [Emetrol Chewables] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2596181 | Emetrol Chewables Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2596182 | Emetrol Chewables Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2596183 | Emetrol Chewables Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2596184 | sodium citrate Chewable Tablet [Emetrol Chewables] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2596185 | Emetrol Chewables 230 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596185 | Emetrol Chewables 230 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596185 | Emetrol Chewables 230 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 259625 | thymus gland-calf 200 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259625 | thymus gland-calf 200 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596269 | Arovyn | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2596270 | tulathromycin 100 MG/ML [Arovyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2596271 | Arovyn Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2596272 | tulathromycin Injectable Solution [Arovyn] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2596273 | Arovyn 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596273 | Arovyn 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596273 | Arovyn 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25964 | Glutathione-cystine transhydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 25964 | Glutathione-cystine transhydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 2596443 | cranberry seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2596444 | mepolizumab 40 MG in 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596444 | mepolizumab 40 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596444 | mepolizumab 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596445 | Nucala 40 MG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2596445 | Nucala 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596445 | Nucala 40 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596445 | Nucala 40 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259645 | Pot gluconate 2.3 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259645 | Pot gluconate 2.3 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259645 | Pot gluconate 2.3 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596543 | camphor 2 % / menthol 4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596543 | camphor 2 % / menthol 4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596543 | camphor 2 % / menthol 4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596641 | colloidal oatmeal 0.0025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2596642 | colloidal oatmeal 0.25 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596642 | colloidal oatmeal 0.25 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596642 | colloidal oatmeal 0.25 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596643 | cetylpyridinium chloride 0.1 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596643 | cetylpyridinium chloride 0.1 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596643 | cetylpyridinium chloride 0.1 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596769 | Glacial acetic acid-containing product in otic dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2596769 | Glacial acetic acid-containing product in otic dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2596770 | nivolumab-rmbw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2596771 | nivolumab-rmbw 12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596772 | relatlimab-rmbw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2596773 | relatlimab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2596774 | relatlimab-rmbw 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596775 | (nivolumab / relatlimab)-rmbw | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596775 | (nivolumab / relatlimab)-rmbw | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2596776 | nivolumab / relatlimab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2596777 | nivolumab / relatlimab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2596778 | nivolumab-relatlimab-rmbw 240 MG / 80 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596778 | nivolumab-relatlimab-rmbw 240 MG / 80 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596778 | nivolumab-relatlimab-rmbw 240 MG / 80 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596779 | nivolumab-rmbw 12 MG/ML / relatlimab-rmbw 4 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596779 | nivolumab-rmbw 12 MG/ML / relatlimab-rmbw 4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259678 | fructooligosaccharide 600 MG / Lactobacillus acidophilus 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596780 | Opdualag | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2596781 | nivolumab-rmbw 12 MG/ML / relatlimab-rmbw 4 MG/ML [Opdualag] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2596782 | Opdualag Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2596783 | nivolumab / relatlimab Injection [Opdualag] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2596784 | Opdualag 240 MG / 80 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2596784 | Opdualag 240 MG / 80 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596784 | Opdualag 240 MG / 80 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596785 | Opdualag 12 MG / 4 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2596785 | Opdualag 12 MG / 4 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596785 | Opdualag 12 MG / 4 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259682 | horse chestnut seed 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596860 | Tasmannia lanceolata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2596861 | sirolimus 0.002 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596862 | sirolimus Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2596863 | sirolimus Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2596864 | sirolimus 0.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596864 | sirolimus 0.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596864 | sirolimus 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596865 | Hyftor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2596866 | sirolimus 0.002 MG/MG [Hyftor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2596867 | Hyftor Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2596868 | sirolimus Topical Gel [Hyftor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2596869 | HYFTOR 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596869 | HYFTOR 0.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596869 | HYFTOR 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596869 | HYFTOR 0.2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 259690 | bee pollen Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 259691 | bee pollen 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259691 | bee pollen 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259695 | bee pollen 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259695 | bee pollen 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596955 | lauryl lactyl lactate, L- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2596956 | upadacitinib 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2596957 | upadacitinib 45 MG 24 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2596957 | upadacitinib 45 MG 24 HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596957 | upadacitinib 45 MG 24 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596958 | upadacitinib 45 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596958 | upadacitinib 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596959 | upadacitinib 45 MG [Rinvoq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 259696 | bee pollen 500 MG / royal jelly 0.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2596960 | RINVOQ 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596960 | RINVOQ 45 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2596960 | RINVOQ 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2596960 | RINVOQ 45 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2596961 | Rinvoq 45 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2596961 | Rinvoq 45 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2596961 | Rinvoq 45 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597 | Clomipramine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2597 | Clomipramine | Designated preferred name (PT) | YES | |
| RxCUI: 2597 | Clomipramine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2597 | Clomipramine | Full form of descriptor (FN) | YES | |
| RxCUI: 2597 | Clomipramine | Designated preferred name (PT) | YES | |
| RxCUI: 2597 | Clomipramine | Full form of descriptor (FN) | YES | |
| RxCUI: 2597042 | lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2597047 | Pluvicto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2597048 | lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML [Pluvicto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2597049 | Pluvicto Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2597052 | lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597052 | lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597053 | lutetium Lu 177 vipivotide tetraxetan | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2597054 | vipivotide tetraxetan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2597055 | vipivotide tetraxetan Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2597056 | vipivotide tetraxetan Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2597057 | lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2597057 | lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597057 | lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597057 | lutetium Lu 177 vipivotide tetraxetan 1000 MBq/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597058 | lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597059 | vipivotide tetraxetan Injection [Pluvicto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2597060 | PLUVICTO 1000 MBq/mL (27 MCI/ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2597060 | PLUVICTO 1000 MBq/mL (27 MCI/ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597060 | PLUVICTO 1000 MBq/mL (27 MCI/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597060 | PLUVICTO 1000 MBq/mL (27 MCI/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259711 | vitamin B 12 600 MCG / mecobalamin 600 MCG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259711 | vitamin B 12 600 MCG / mecobalamin 600 MCG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259711 | vitamin B 12 600 MCG / mecobalamin 600 MCG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259711 | vitamin B 12 600 MCG / mecobalamin 600 MCG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259714 | coal tar 7 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259714 | coal tar 7 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259714 | coal tar 7 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259719 | melatonin 3 MG / vitamin B6 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259719 | melatonin 3 MG / vitamin B6 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259721 | choline / glutamine / inositol Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2597249 | Ligustrum lucidum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2597250 | sodium fluoride 0.05 % Oral Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597250 | sodium fluoride 0.05 % Oral Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597250 | sodium fluoride 0.05 % Oral Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259731 | procyanidolic oligomer 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259732 | procyanidolic oligomer 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259733 | procyanidolic oligomer 30 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259740 | calcium glucarate 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259743 | calcium carbonate 200 MG / docosahexaenoic acid 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259744 | glucosamine sulfate 500 MG / methylsulfonylmethane 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597442 | donepezil 0.208 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2597443 | donepezil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2597444 | donepezil Transdermal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2597445 | donepezil Transdermal System | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2597446 | donepezil 5 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2597446 | donepezil 5 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597447 | donepezil 0.208 MG/HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597447 | donepezil 0.208 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597448 | Adlarity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2597449 | donepezil 0.208 MG/HR [Adlarity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2597450 | Adlarity Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2597451 | Adlarity Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2597452 | donepezil Transdermal System [Adlarity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2597453 | Adlarity 5 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597453 | Adlarity 5 MG/Day Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2597453 | Adlarity 5 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597454 | Adlarity 0.208 MG/HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597454 | Adlarity 0.208 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597454 | Adlarity 0.208 MG/HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597455 | donepezil 0.417 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2597456 | donepezil 10 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2597456 | donepezil 10 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597457 | donepezil 0.417 MG/HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597457 | donepezil 0.417 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597458 | donepezil 0.417 MG/HR [Adlarity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2597459 | Adlarity 10 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597459 | Adlarity 10 MG/Day Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2597459 | Adlarity 10 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597460 | Adlarity 0.417 MG/HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597460 | Adlarity 0.417 MG/HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597460 | Adlarity 0.417 MG/HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259750 | calcium citrate 500 UNT / cholecalciferol 200 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259752 | isometheptene mucate 130 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259752 | isometheptene mucate 130 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597521 | N-acetyl-glucosamine thiazoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2597522 | PEG-7 trimethylolpropane coconut ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2597523 | hypotaurine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2597524 | camphor / colloidal oatmeal | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2597525 | camphor / colloidal oatmeal Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2597526 | camphor / colloidal oatmeal Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2597527 | camphor 1 % / colloidal oatmeal 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597527 | camphor 1 % / colloidal oatmeal 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597527 | camphor 1 % / colloidal oatmeal 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597528 | lidocaine hydrochloride 40 MG/ML [Lidocream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2597529 | Lidocream Plus 4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597529 | Lidocream Plus 4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597529 | Lidocream Plus 4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259753 | ginger root extract 550 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259753 | ginger root extract 550 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597530 | Red Hot | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2597531 | capsaicin 0.0005 MG/MG [Red Hot] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2597532 | Red Hot Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2597533 | capsaicin Topical Ointment [Red Hot] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2597534 | Red Hot 0.05 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597534 | Red Hot 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597534 | Red Hot 0.05 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597534 | Red Hot 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597535 | Atomic Balm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2597536 | capsaicin 0.00025 MG/MG / methyl salicylate 0.125 MG/MG [Atomic Balm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2597537 | Atomic Balm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2597538 | capsaicin / methyl salicylate Topical Ointment [Atomic Balm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2597539 | Atomic Balm 0.025 % / 12.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597539 | Atomic Balm 0.025 % / 12.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2597539 | Atomic Balm 0.025 % / 12.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259754 | ginseng root 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597540 | Skin-Lube | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2597541 | dimethicone 0.015 MG/MG / petrolatum 0.85 MG/MG [Skin-Lube] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2597542 | Skin-Lube Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2597543 | dimethicone / petrolatum Topical Ointment [Skin-Lube] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2597544 | Skin-Lube 1.5 % / 85 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597544 | Skin-Lube 1.5 % / 85 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2597544 | Skin-Lube 1.5 % / 85 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 25976 | Glycerate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 25976 | Glycerate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 259760 | ferrous fumarate 90 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259760 | ferrous fumarate 90 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259760 | ferrous fumarate 90 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2597666 | Breyna | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2597667 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT [Breyna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2597668 | Breyna Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2597669 | budesonide / formoterol Metered Dose Inhaler [Breyna] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2597670 | Breyna 160 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2597670 | Breyna 160 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597670 | Breyna 160 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597671 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Breyna] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2597672 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT [Breyna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2597673 | Breyna 80 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2597673 | Breyna 80 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2597673 | Breyna 80 MCG / 4.5 MCG Metered Dose Inhaler, 120 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2597674 | budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Breyna] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259768 | soy isoflavone 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259768 | soy isoflavone 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 25977 | Glycerate kinase | Designated preferred name (PT) | NO | |
| RxCUI: 25977 | Glycerate kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 259772 | vit-C 150 MG / FESO4 65 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259772 | vit-C 150 MG / FESO4 65 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259772 | vit-C 150 MG / FESO4 65 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259772 | vit-C 150 MG / FESO4 65 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259773 | ferrous sulfate 65 MG / ascorbic acid 150 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259773 | ferrous sulfate 65 MG / ascorbic acid 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259773 | ferrous sulfate 65 MG / ascorbic acid 150 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259773 | ferrous sulfate 65 MG / ascorbic acid 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259773 | ferrous sulfate 65 MG / ascorbic acid 150 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259778 | estradiol 1 MG / norgestimate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259785 | horse chestnut seed 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259790 | calcium citrate 133 UNT / vitamin D3 66 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259790 | calcium citrate 133 UNT / vitamin D3 66 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259791 | copper gluconate 2 MG / zinc picolinate 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259796 | coenzyme Q10 120 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259796 | coenzyme Q10 120 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259796 | coenzyme Q10 120 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598 | Clonazepam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2598 | Clonazepam | Designated preferred name (PT) | YES | |
| RxCUI: 2598 | Clonazepam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598 | Clonazepam | Full form of descriptor (FN) | YES | |
| RxCUI: 2598 | Clonazepam | Designated preferred name (PT) | YES | |
| RxCUI: 2598 | Clonazepam | Full form of descriptor (FN) | YES | |
| RxCUI: 2598015 | Cynanchum otophyllum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2598017 | alpha-tocopherol calcium succinate, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2598117 | imidacloprid 100 MG/ML / moxidectin 10 MG/ML [Midamox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598118 | Midamox for Cats 10 % / 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598118 | Midamox for Cats 10 % / 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598118 | Midamox for Cats 10 % / 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598119 | indole-3-carbinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2598120 | methane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2598123 | methoxychlor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2598124 | dextromethorphan / guaifenesin Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598124 | dextromethorphan / guaifenesin Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598125 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598125 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598125 | dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG Effervescent Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598127 | succinylcholine Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598128 | succinylcholine chloride 100 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598128 | succinylcholine chloride 100 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598128 | succinylcholine chloride 100 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598129 | succinylcholine chloride 20 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598160 | melatonin 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598161 | melatonin 10 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598161 | melatonin 10 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598162 | lidocaine HCl 4 % / menthol 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598162 | lidocaine HCl 4 % / menthol 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598162 | lidocaine HCl 4 % / menthol 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259821 | chlorophyllin 60 MG / soybean oil 453 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598241 | calamine 2 % / zinc oxide 20.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598241 | calamine 2 % / zinc oxide 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598241 | calamine 2 % / zinc oxide 20.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598241 | calamine 2 % / zinc oxide 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598242 | strontium-89 chloride 1 MCI/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598243 | strontium Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2598244 | strontium Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598245 | strontium-89 chloride 37 MBq/ml (1 MCI/ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598245 | strontium-89 chloride 37 MBq/ml (1 MCI/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598245 | strontium-89 chloride 37 MBq/ml (1 MCI/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598245 | strontium-89 chloride 37 MBq/ml (1 MCI/ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598246 | strontium-89 chloride 1 MCI/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598342 | labetalol Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598343 | labetalol hydrochloride 10 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598343 | labetalol hydrochloride 10 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598343 | labetalol hydrochloride 10 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598343 | labetalol hydrochloride 10 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598344 | labetalol hydrochloride 5 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598345 | abacavir 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598346 | abacavir / dolutegravir / lamivudine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2598346 | abacavir / dolutegravir / lamivudine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598347 | abacavir / dolutegravir / lamivudine Tablet for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598347 | abacavir / dolutegravir / lamivudine Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598348 | abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598349 | abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG [Triumeq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2598349 | abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG [Triumeq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598350 | Triumeq Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2598351 | abacavir / dolutegravir / lamivudine Tablet for Oral Suspension [Triumeq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2598351 | abacavir / dolutegravir / lamivudine Tablet for Oral Suspension [Triumeq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2598352 | Triumeq PD 60 MG / 5 MG / 30 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259838 | kava root 110 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25984 | Dihydroxyacetone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25984 | Dihydroxyacetone reductase | Designated preferred name (PT) | NO | |
| RxCUI: 25984 | Dihydroxyacetone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25984 | Dihydroxyacetone reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 259843 | calcium phosphate 154 MG / procyanidolic oligomer 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598438 | Movodyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2598439 | carprofen 100 MG [Movodyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 259844 | glucosamine sulfate 250 MG / chondroitin sulfate A 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259844 | glucosamine sulfate 250 MG / chondroitin sulfate A 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598440 | Movodyl Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598441 | Movodyl Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598442 | Movodyl Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598443 | carprofen Chewable Tablet [Movodyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2598444 | MOVODYL 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598444 | MOVODYL 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598444 | MOVODYL 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598445 | carprofen 25 MG [Movodyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598446 | MOVODYL 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598446 | MOVODYL 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598446 | MOVODYL 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598447 | carprofen 75 MG [Movodyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598448 | MOVODYL 75 Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598448 | MOVODYL 75 Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598448 | MOVODYL 75 Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598449 | Dodex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2598450 | vitamin B12 1 MG/ML [Dodex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2598451 | Dodex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2598452 | vitamin B12 Injectable Solution [Dodex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2598453 | Dodex 1000 MCG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598453 | Dodex 1000 MCG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598453 | Dodex 1000 MCG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2598454 | Vijoice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2598455 | alpelisib 50 MG [Vijoice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2598456 | Vijoice Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2598457 | Vijoice Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2598458 | alpelisib Oral Tablet [Vijoice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2598459 | Vijoice 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2598459 | Vijoice 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598459 | Vijoice 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598460 | alpelisib 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598461 | alpelisib 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598461 | alpelisib 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598462 | alpelisib 125 MG [Vijoice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2598463 | Vijoice 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2598463 | Vijoice 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598463 | Vijoice 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598464 | alpelisib 125 MG Oral Tablet, 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2598464 | alpelisib 125 MG Oral Tablet, 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598464 | alpelisib 125 MG Oral Tablet, 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598465 | Vijoice 125 MG 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2598465 | Vijoice 125 MG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598465 | Vijoice 125 MG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598466 | alpelisib 50 MG 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2598466 | alpelisib 50 MG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598466 | alpelisib 50 MG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598467 | Vijoice 50 MG 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2598467 | Vijoice 50 MG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598467 | Vijoice 50 MG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598468 | alpelisib 200 MG [Vijoice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2598469 | Vijoice 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2598469 | Vijoice 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598469 | Vijoice 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598470 | Vijoice 250 MG 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2598470 | Vijoice 250 MG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598470 | Vijoice 250 MG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 25985 | Glycerol-3-phosphate dehydrogenase (nicotinamide adenine dinucleotide ^+^) | Designated preferred name (PT) | NO | |
| RxCUI: 25985 | Glycerol-3-phosphate dehydrogenase (nicotinamide adenine dinucleotide ^+^) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25985 | Glycerol-3-phosphate dehydrogenase (nicotinamide adenine dinucleotide ^+^) | Full form of descriptor (FN) | NO | |
| RxCUI: 259853 | chloroxylenol 0.43 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259853 | chloroxylenol 0.43 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259853 | chloroxylenol 0.43 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598541 | Umbrellin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2598542 | amoxicillin 100 MG / clavulanate 25 MG [Umbrellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598543 | Umbrellin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598544 | Umbrellin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598545 | amoxicillin / clavulanate Oral Tablet [Umbrellin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2598546 | Umbrellin 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598546 | Umbrellin 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598546 | Umbrellin 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598547 | amoxicillin 200 MG / clavulanate 50 MG [Umbrellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598548 | Umbrellin 250 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598548 | Umbrellin 250 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598548 | Umbrellin 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598549 | amoxicillin 300 MG / clavulanate 75 MG [Umbrellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598550 | Umbrellin 375 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598550 | Umbrellin 375 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598550 | Umbrellin 375 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598551 | amoxicillin 50 MG / clavulanate 12.5 MG [Umbrellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598552 | Umbrellin 62.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598552 | Umbrellin 62.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598552 | Umbrellin 62.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598553 | amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Umbrellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598554 | Umbrellin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598555 | amoxicillin / clavulanate Oral Suspension [Umbrellin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2598556 | Umbrellin 50 MG / 12.5 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598556 | Umbrellin 50 MG / 12.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598556 | Umbrellin 50 MG / 12.5 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598590 | enrofloxacin 22.7 MG [Enroflox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598591 | Enroflox Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598592 | Enroflox Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598593 | Enroflox Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2598594 | enrofloxacin Chewable Tablet [Enroflox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2598595 | Enroflox 22.7 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598595 | Enroflox 22.7 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598595 | Enroflox 22.7 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2598598 | enrofloxacin 68 MG [Enroflox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2598599 | Enroflox 68 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598599 | Enroflox 68 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598599 | Enroflox 68 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259862 | ginseng root 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598688 | menatetrenone 0.09 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598689 | cholecalciferol 125 MCG / menatetrenone 90 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598689 | cholecalciferol 125 MCG / menatetrenone 90 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598689 | cholecalciferol 125 MCG / menatetrenone 90 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598690 | melatonin 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2598691 | melatonin Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2598692 | melatonin 0.75 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598692 | melatonin 0.75 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598692 | melatonin 0.75 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598693 | melatonin 0.25 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2598693 | melatonin 0.25 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2598693 | melatonin 0.25 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598694 | theanine 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2598695 | theanine 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598695 | theanine 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598695 | theanine 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598699 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 259870 | vitamin A 1250 UNT / ergocalciferol 135 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259870 | vitamin A 1250 UNT / ergocalciferol 135 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259870 | vitamin A 1250 UNT / ergocalciferol 135 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259870 | vitamin A 1250 UNT / ergocalciferol 135 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 259870 | vitamin A 1250 UNT / ergocalciferol 135 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2598700 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2598700 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2598700 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2598700 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25988 | Glycerol dehydratase | Designated preferred name (PT) | NO | |
| RxCUI: 25988 | Glycerol dehydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 259883 | dimethicone 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259883 | dimethicone 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 259883 | dimethicone 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 259886 | bromelains 133333 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259887 | arginine 1000 MG / calcium carbonate 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259888 | chromium picolinate 200 MCG / gamboge 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259888 | chromium picolinate 200 MCG / gamboge 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 25989 | Glycerol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 25989 | Glycerol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 259894 | sulfur 64 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599 | Clonidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2599 | Clonidine | Designated preferred name (PT) | YES | |
| RxCUI: 2599 | Clonidine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599 | Clonidine | Full form of descriptor (FN) | YES | |
| RxCUI: 2599 | Clonidine | Designated preferred name (PT) | YES | |
| RxCUI: 2599 | Clonidine | Full form of descriptor (FN) | YES | |
| RxCUI: 259903 | American ginseng root 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599041 | bevacizumab-maly | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2599042 | bevacizumab-maly 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599043 | bevacizumab-maly 100 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599043 | bevacizumab-maly 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599043 | bevacizumab-maly 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599043 | bevacizumab-maly 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599044 | bevacizumab-maly 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599045 | Alymsys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2599046 | bevacizumab-maly 25 MG/ML [Alymsys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599047 | Alymsys Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599048 | bevacizumab Injection [Alymsys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599049 | Alymsys 100 MG in 4 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599049 | Alymsys 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599049 | Alymsys 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599049 | Alymsys 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599050 | bevacizumab-maly 25 MG/ML Injection [Alymsys] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599050 | bevacizumab-maly 25 MG/ML Injection [Alymsys] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599051 | bevacizumab-maly 400 MG in 16 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599051 | bevacizumab-maly 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599051 | bevacizumab-maly 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599051 | bevacizumab-maly 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599052 | Alymsys 400 MG in 16 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599052 | Alymsys 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599052 | Alymsys 400 MG in 16 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599052 | Alymsys 400 MG in 16 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599053 | testosterone undecanoate 112.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599054 | testosterone undecanoate 112.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599054 | testosterone undecanoate 112.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599055 | Tlando | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2599056 | testosterone undecanoate 112.5 MG [Tlando] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599057 | Tlando Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599058 | Tlando Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599059 | testosterone Oral Capsule [Tlando] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599060 | TLANDO 112.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599060 | TLANDO 112.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599060 | TLANDO 112.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599061 | Xysed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2599062 | xylazine 100 MG/ML [Xysed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599063 | Xysed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599064 | xylazine Injectable Solution [Xysed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599065 | Xysed 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599065 | Xysed 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599065 | Xysed 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599065 | Xysed 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599084 | tulathromycin 25 MG/ML [Increxxa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599085 | Increxxa 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599085 | Increxxa 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599085 | Increxxa 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 259909 | Korean ginseng root 518 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259909 | Korean ginseng root 518 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259909 | Korean ginseng root 518 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599095 | daridorexant 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599096 | daridorexant 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599096 | daridorexant 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599096 | daridorexant 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599097 | daridorexant 50 MG [Quviviq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599098 | QUVIVIQ 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599098 | QUVIVIQ 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599098 | QUVIVIQ 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259910 | Korean ginseng root 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259910 | Korean ginseng root 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259910 | Korean ginseng root 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599170 | lidocaine Vaginal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2599171 | lidocaine HCl 4 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599171 | lidocaine HCl 4 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599171 | lidocaine HCl 4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599172 | amlodipine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2599172 | amlodipine Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599173 | amLODIPine 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599173 | amLODIPine 1 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599173 | amLODIPine 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599173 | amLODIPine 1 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599173 | amLODIPine 1 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599174 | Norliqva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2599175 | amlodipine 1 MG/ML [Norliqva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599175 | amlodipine 1 MG/ML [Norliqva] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599176 | Norliqva Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599177 | Norliqva Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599178 | amlodipine Oral Solution [Norliqva] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599178 | amlodipine Oral Solution [Norliqva] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599179 | Norliqva 1 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599179 | Norliqva 1 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599179 | Norliqva 1 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599179 | Norliqva 1 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599179 | Norliqva 1 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599180 | petrolatum 350 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599181 | mineral oil / petrolatum Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2599182 | mineral oil 55 % / petrolatum 35 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599182 | mineral oil 55 % / petrolatum 35 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599182 | mineral oil 55 % / petrolatum 35 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259919 | calcium phosphate 43 MG / prasterone 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599242 | doxepin 10 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599244 | doxepin 10 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599246 | doxepin 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599248 | doxepin 10 MG/ML [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599251 | doxepin 100 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599253 | doxepin 100 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599255 | doxepin 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599257 | doxepin 150 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599259 | doxepin 150 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599262 | doxepin 25 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599264 | doxepin 25 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599267 | doxepin 50 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599269 | doxepin 50 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599272 | doxepin 75 MG [Sinequan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599274 | doxepin 75 MG [Adapin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599276 | clonidine 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599276 | clonidine 0.09 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2599279 | clonidine 0.09 MG/ML [Nexiclon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599279 | clonidine 0.09 MG/ML [Nexiclon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2599282 | clonidine 0.17 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599282 | clonidine 0.17 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2599284 | cloNIDine 0.17 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599284 | cloNIDine 0.17 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599284 | cloNIDine 0.17 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2599285 | clonidine 0.17 MG [Nexiclon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599285 | clonidine 0.17 MG [Nexiclon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 259931 | horse chestnut seed 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259931 | horse chestnut seed 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599310 | Berberis aristata fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 259934 | soy protein isolate 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259934 | soy protein isolate 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259935 | Korean ginseng root 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259935 | Korean ginseng root 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599359 | sodium bicarbonate 1650 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599360 | citric acid 1000 MG / sodium bicarbonate 1650 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599360 | citric acid 1000 MG / sodium bicarbonate 1650 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599360 | citric acid 1000 MG / sodium bicarbonate 1650 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599361 | semaglutide 2.68 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599362 | semaglutide 8 MG in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599362 | semaglutide 8 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599362 | semaglutide 8 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599362 | semaglutide 8 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599363 | semaglutide 2.68 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599364 | semaglutide 2.68 MG/ML [Ozempic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599366 | semaglutide 2.68 MG/ML Pen Injector [Ozempic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599366 | semaglutide 2.68 MG/ML Pen Injector [Ozempic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599367 | oleth-4 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2599368 | Carprodyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2599369 | carprofen 50 MG/ML [Carprodyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599370 | Carprodyl Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599371 | carprofen Injectable Solution [Carprodyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599372 | Carprodyl 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599372 | Carprodyl 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599372 | Carprodyl 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25995 | Glycerol-1-phosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 25995 | Glycerol-1-phosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 2599510 | dotatate Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2599511 | dotatate Injection [Lutathera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599512 | dotatate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2599513 | meloxicam 5 MG/ML [Meloxidyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599514 | Meloxidyl Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599515 | meloxicam Injectable Solution [Meloxidyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599516 | Meloxidyl 5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599516 | Meloxidyl 5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599516 | Meloxidyl 5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599517 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599517 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599517 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599518 | Brincidofovir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2599518 | Brincidofovir | Designated preferred name (PT) | YES | |
| RxCUI: 2599518 | Brincidofovir | Full form of descriptor (FN) | YES | |
| RxCUI: 2599518 | Brincidofovir | Designated preferred name (PT) | YES | |
| RxCUI: 2599518 | Brincidofovir | Full form of descriptor (FN) | YES | |
| RxCUI: 2599519 | lidocaine 4 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599519 | lidocaine 4 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599519 | lidocaine 4 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599520 | menthol 1.4 % / methyl salicylate 10 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599520 | menthol 1.4 % / methyl salicylate 10 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599520 | menthol 1.4 % / methyl salicylate 10 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599521 | brincidofovir 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599522 | brincidofovir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2599523 | brincidofovir Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2599524 | brincidofovir Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2599525 | brincidofovir 10 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599525 | brincidofovir 10 MG/mL Oral Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 2599525 | brincidofovir 10 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599525 | brincidofovir 10 MG/mL Oral Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 2599526 | Tembexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2599527 | brincidofovir 10 MG/ML [Tembexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599528 | Tembexa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599529 | Tembexa Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 259953 | belladonna alkaloids 0.0194 MG / simethicone 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599530 | brincidofovir Oral Suspension [Tembexa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599531 | TEMBEXA 10 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599531 | TEMBEXA 10 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599531 | TEMBEXA 10 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599532 | brincidofovir 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599533 | brincidofovir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2599534 | brincidofovir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2599535 | brincidofovir 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599535 | brincidofovir 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 2599535 | brincidofovir 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599535 | brincidofovir 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 2599536 | brincidofovir 100 MG [Tembexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599537 | Tembexa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599538 | brincidofovir Oral Tablet [Tembexa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599539 | TEMBEXA 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599539 | TEMBEXA 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599539 | TEMBEXA 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599540 | brincidofovir 4 Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2599540 | brincidofovir 4 Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599540 | brincidofovir 4 Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599541 | TEMBEXA 4 Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2599541 | TEMBEXA 4 Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599541 | TEMBEXA 4 Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599542 | nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2599542 | nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599542 | nirmatrelvir 150 MG ; ritonavir 100 MG Daily Dose Pack, Renal | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599543 | PAXLOVID 150 MG ; 100 MG Dose Pack, Renal | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2599543 | PAXLOVID 150 MG ; 100 MG Dose Pack, Renal | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599543 | PAXLOVID 150 MG ; 100 MG Dose Pack, Renal | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259955 | belladonna alkaloids 0.0065 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599581 | beryllium fluoride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2599608 | calcium carbonate 80 MG/mL / simethicone 8 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599608 | calcium carbonate 80 MG/mL / simethicone 8 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599609 | calcium carbonate 80 MG/ML / simethicone 8 MG/ML [Mylicon Children's] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599610 | Mylicon Children's Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2599611 | calcium carbonate / simethicone Oral Suspension [Mylicon Children's] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2599612 | MYLICON Children's 400 MG / 40 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2599612 | MYLICON Children's 400 MG / 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599612 | MYLICON Children's 400 MG / 40 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599613 | menthol 15.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599614 | menthol 15.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599614 | menthol 15.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599615 | menthol 15.3 MG [Ricola] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599616 | Ricola 15.3 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599616 | Ricola 15.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599616 | Ricola 15.3 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599617 | menthol 8.3 MG [Ricola] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599618 | Ricola 8.3 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599618 | Ricola 8.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599618 | Ricola 8.3 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599619 | triethanolamine myristate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2599620 | Liceout | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2599621 | piperonyl butoxide 30 MG/ML / pyrethrins 3 MG/ML [Liceout] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599622 | Liceout Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599623 | piperonyl butoxide / pyrethrins Medicated Shampoo [Liceout] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599624 | Liceout 3 % / 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599624 | Liceout 3 % / 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599624 | Liceout 3 % / 0.3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599626 | sodium hyaluronate 11 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599627 | sodium hyaluronate 22 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599627 | sodium hyaluronate 22 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599627 | sodium hyaluronate 22 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599628 | sodium hyaluronate 11 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599628 | sodium hyaluronate 11 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599629 | Hyvisc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2599630 | sodium hyaluronate 11 MG/ML [Hyvisc] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599631 | Hyvisc Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599632 | hyaluronate Prefilled Syringe [Hyvisc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599633 | Hyvisc 22 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599633 | Hyvisc 22 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599633 | Hyvisc 22 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599633 | Hyvisc 22 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599634 | Hyvisc 11 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599634 | Hyvisc 11 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599634 | Hyvisc 11 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599635 | hydrocortisone 1 % / lidocaine hydrochloride 3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599635 | hydrocortisone 1 % / lidocaine hydrochloride 3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599635 | hydrocortisone 1 % / lidocaine hydrochloride 3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259965 | melatonin 3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259966 | methylPREDNISolone 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 259966 | methylPREDNISolone 4 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 259966 | methylPREDNISolone 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 259966 | methylPREDNISolone 4 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 259966 | methylPREDNISolone 4 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 25997 | Glycerol 2-phosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 25997 | Glycerol 2-phosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 25998 | CDPglycerol pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25998 | CDPglycerol pyrophosphorylase | Designated preferred name (PT) | NO | |
| RxCUI: 25998 | CDPglycerol pyrophosphorylase | Full form of descriptor (FN) | NO | |
| RxCUI: 2599841 | benzocaine Rectal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2599842 | benzocaine 5 % Rectal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599842 | benzocaine 5 % Rectal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599842 | benzocaine 5 % Rectal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599843 | menthol 11 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599843 | menthol 11 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599843 | menthol 11 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599844 | buprenorphine 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599845 | buprenorphine Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2599846 | buprenorphine 20 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599846 | buprenorphine 20 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599847 | Zorbium | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2599848 | buprenorphine 20 MG/ML [Zorbium] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2599849 | Zorbium Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2599850 | buprenorphine Topical Solution [Zorbium] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599851 | Zorbium 20 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2599851 | Zorbium 20 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599851 | Zorbium 20 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25999 | Glycerophosphocholine cholinephosphodiesterase | Designated preferred name (PT) | NO | |
| RxCUI: 25999 | Glycerophosphocholine cholinephosphodiesterase | Full form of descriptor (FN) | NO | |
| RxCUI: 2599920 | Adenium obesum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2599921 | ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2599922 | 2-(MPEG 2000)-N,N-ditetradecylacetamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2599923 | sulfur 33 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2599924 | sulfur 3.3 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2599924 | sulfur 3.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2599924 | sulfur 3.3 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259994 | kava root 500 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 259999 | kava root 275 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2599990 | polysaccharide iron complex 326.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2599991 | polysaccharide iron complex 326.1 MG (iron 150 MG) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2599991 | polysaccharide iron complex 326.1 MG (iron 150 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2599991 | polysaccharide iron complex 326.1 MG (iron 150 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2599992 | polysaccharide iron complex 326.1 MG [Iferex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2599995 | ampicillin Oral Suspension [Omnipen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2599997 | ampicillin Oral Suspension [Totacillin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |